<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">94310</article-id>
<article-id pub-id-type="doi">10.7554/eLife.94310</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.94310.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories><title-group>
<article-title>Inhibition of the UFD-1-NPL-4 complex triggers an aberrant immune response in <italic>Caenorhabditis elegans</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Rajneesh</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5975-3352</contrib-id>
<name>
<surname>Aballay</surname>
<given-names>Alejandro</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7947-0405</contrib-id>
<name>
<surname>Singh</surname>
<given-names>Jogender</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>jogender@iisermohali.ac.in</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vztzd79</institution-id><institution>Department of Biological Sciences, Indian Institute of Science Education and Research</institution></institution-wrap>, <city>Mohali</city>, <country country="IN">India</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04twxam07</institution-id><institution>Department of Genetics, The University of Texas MD Anderson Cancer Center</institution></institution-wrap>, <city>Houston</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Vance</surname>
<given-names>Russell E</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of California, Berkeley</institution>
</institution-wrap>
<city>Berkeley</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Taniguchi</surname>
<given-names>Tadatsugu</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>The University of Tokyo</institution>
</institution-wrap>
<city>Tokyo</city>
<country country="JP">Japan</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-02-05">
<day>05</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-09-01">
<day>01</day>
<month>09</month>
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP94310</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-11-28">
<day>28</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-12-13">
<day>13</day>
<month>12</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.12.12.571255"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2024-02-05">
<day>05</day>
<month>02</month>
<year>2024</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.94310.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.94310.1.sa2">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.94310.1.sa1">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.94310.1.sa0">Reviewer #2 (Public Review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Rao et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Rao et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-94310-v2.pdf"/>
<abstract>
<title>Abstract</title><p>The UFD-1 (ubiquitin fusion degradation 1)-NPL-4 (nuclear protein localization homolog 4) heterodimer is involved in extracting ubiquitinated proteins from several plasma membrane locations, including the endoplasmic reticulum. This heterodimer complex helps in the degradation of ubiquitinated proteins via the proteasome with the help of the AAA+ ATPase CDC-48. While the ubiquitin-proteasome system is known to have important roles in maintaining innate immune responses, the role of the UFD-1-NPL-4 complex in regulating immunity remains elusive. In this study, we investigate the role of the UFD-1-NPL-4 complex in maintaining <italic>Caenorhabditis elegans</italic> innate immune responses. Inhibition of the UFD-1-NPL-4 complex activates an aberrant immune response that reduces the survival of the wild-type worms on the pathogenic bacterium <italic>Pseudomonas aeruginosa</italic> despite diminishing colonization of the gut with the bacterium. This aberrant immune response improves the survival of severely immunocompromised worms on pathogenic bacteria but is detrimental on nonpathogenic bacteria. Transcriptomics studies reveal that the GATA transcription factor ELT-2 mediates the aberrant immune response upon inhibition of the UFD-1-NPL-4 complex. Collectively, our findings show that inhibition of the UFD-1-NPL-4 complex triggers an aberrant immune response that is detrimental to immunocompetent worms under infection conditions but can be advantageous for immunocompromised worms.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Colonization</kwd>
<kwd>ERAD</kwd>
<kwd>GATA transcription factor</kwd>
<kwd>immune response</kwd>
<kwd>ubiquitin-proteasome system</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03tjsyq23</institution-id>
<institution>Department of Biotechnology</institution>
</institution-wrap>
</funding-source>
<award-id>BT/RLF/Re-entry/50/2020</award-id>
</award-group>
<award-group id="funding-1a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03tjsyq23</institution-id>
<institution>Department of Biotechnology</institution>
</institution-wrap>
</funding-source>
<award-id>HRD-17011/2/2023-HRD-DBT</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution>Ministry of Education, India</institution>
</institution-wrap>
</funding-source>
<award-id>MoE-STARS/STARS-2/2023-0116</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03ffdsr55</institution-id>
<institution>Science and Engineering Research Board</institution>
</institution-wrap>
</funding-source>
<award-id>SRG/2020/000022</award-id>
</award-group>
<award-group id="funding-3a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03ffdsr55</institution-id>
<institution>Science and Engineering Research Board</institution>
</institution-wrap>
</funding-source>
<award-id>CRG/2023/001136</award-id>
</award-group>
<award-group id="funding-4">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/021wm7p51</institution-id>
<institution>Council of Scientific and Industrial Research</institution>
</institution-wrap>
</funding-source>
<award-id>37/1741/23/EMR-II</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Several new experiments have been added, including RNAi specificity test, ELT-2 overexpression, defecation assays, and gfp RNAi control for double RNAi experiments.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Maintenance of a healthy proteome involves the degradation of misfolded proteins (<xref ref-type="bibr" rid="c59">Vembar and Brodsky, 2008</xref>; <xref ref-type="bibr" rid="c60">Vilchez et al., 2014</xref>). Proteasomes are a major site for the degradation of misfolded proteins (<xref ref-type="bibr" rid="c8">Clague and Urbe, 2010</xref>; <xref ref-type="bibr" rid="c12">Ding and Yin, 2008</xref>). Proteins are tagged for proteasomal degradation by ubiquitin through a series of enzymatic reactions (<xref ref-type="bibr" rid="c10">Dikic, 2017</xref>). In addition to the proteasomal degradation of proteins, ubiquitination controls a vast array of cellular signals and functions (<xref ref-type="bibr" rid="c22">Husnjak and Dikic, 2012</xref>; <xref ref-type="bibr" rid="c36">Mukhopadhyay and Riezman, 2007</xref>). The ubiquitination pathways also have important roles in innate immunity regulation (<xref ref-type="bibr" rid="c14">Garcia-Sanchez et al., 2021</xref>; <xref ref-type="bibr" rid="c27">Li et al., 2016</xref>). The host ubiquitination pathways are involved in the targeting of bacterial proteins, lipopolysaccharides, and bacteria-containing vacuoles, resulting in selective macroautophagy or xenophagy of bacterial pathogens (<xref ref-type="bibr" rid="c6">Chai et al., 2019</xref>; <xref ref-type="bibr" rid="c17">Haldar et al., 2015</xref>; <xref ref-type="bibr" rid="c39">Otten et al., 2021</xref>; <xref ref-type="bibr" rid="c58">Tripathi-Giesgen et al., 2021</xref>). Because of the important roles of ubiquitination in host defenses, bacterial pathogens have evolved multiple strategies to target the host ubiquitination pathways (<xref ref-type="bibr" rid="c4">Bomberger et al., 2011</xref>; <xref ref-type="bibr" rid="c19">Herhaus and Dikic, 2018</xref>; <xref ref-type="bibr" rid="c44">Ribet and Cossart, 2018</xref>). Therefore, it is possible that inhibition of the ubiquitination pathways would activate immune responses via compensatory mechanisms.</p>
<p>The proteasomal degradation requires ubiquitin-tagged proteins to be unfolded and extracted from macromolecular complexes (Boom and Meyer, 2018). CDC-48 (VCP/p97 in vertebrates) is a highly conserved AAA+ ATPase that uses its protein unfoldase activity to extract a variety of ubiquitinated polypeptides from membranes or macromolecular complexes (<xref ref-type="bibr" rid="c3">Bodnar and Rapoport, 2017</xref>; <xref ref-type="bibr" rid="c32">Meyer et al., 2012</xref>). CDC-48 uses different cofactor proteins to recognize its client proteins (<xref ref-type="bibr" rid="c32">Meyer et al., 2012</xref>). The UFD-1 (ubiquitin fusion degradation 1)-NPL-4 (nuclear protein localization homolog 4) heterodimer is a CDC-48 cofactor that is involved in the extraction of misfolded and ubiquitinated proteins from several plasma membrane locations, including the endoplasmic reticulum (ER) (<xref ref-type="bibr" rid="c33">Meyer et al., 2000</xref>; <xref ref-type="bibr" rid="c62">Wolf and Stolz, 2012</xref>; <xref ref-type="bibr" rid="c66">Ye et al., 2001</xref>). Therefore, the UFD-1-NPL-4 complex is critical for the ER-associated degradation (ERAD) of misfolded proteins (<xref ref-type="bibr" rid="c63">Wu and Rapoport, 2018</xref>). In addition to ERAD, the ER has evolved other strategies to deal with misfolded proteins (<xref ref-type="bibr" rid="c49">Singh, 2023</xref>), including a series of unfolded protein response (UPR) pathways that enhance the folding capacity of the ER by synthesis of molecular chaperones and reduction of protein translation (<xref ref-type="bibr" rid="c20">Hetz et al., 2015</xref>). The ER-UPR pathways are required for an optimum immune response (<xref ref-type="bibr" rid="c13">Engel and Barton, 2010</xref>; <xref ref-type="bibr" rid="c45">Richardson et al., 2010</xref>; <xref ref-type="bibr" rid="c54">Sun et al., 2012</xref>).</p>
<p>However, the role of the UFD-1-NPL-4 complex, which is required for ERAD, in regulating immune responses remains poorly explored. Because ubiquitin-dependent pathways have important roles in immunity, it will be interesting to explore the role of the UFD-1-NPL-4 complex in regulating immune responses.</p>
<p>In this study, we showed that the inhibition of the UFD-1-NPL-4 complex results in the activation of an aberrant immune response in <italic>Caenorhabditis elegans</italic>. The wild-type worms had a significant reduction in survival on the pathogenic bacterium <italic>Pseudomonas aeruginosa</italic> despite having diminished colonization of the gut with the bacterium. Inhibition of the UFD-1-NPL-4 complex also led to diminished bacterial colonization in mutants of ER-UPR and immunity pathways. The diminished bacterial colonization improved the survival of severely immunocompromised mutants on pathogenic bacteria. However, on nonpathogenic bacteria, on which the severely immunocompromised mutants exhibit a normal lifespan, inhibition of the UFD-1-NPL-4 complex resulted in a significant reduction in lifespan.</p>
<p>Transcriptomic studies revealed that inhibition of the UFD-1-NPL-4 complex resulted in the activation of the intracellular pathogen response. Analysis for transcription factor enrichment for upregulated genes identified that the GATA transcription factor ELT-2 mediated the aberrant immune response upon inhibition of the UFD-1-NPL-4 complex. Thus, our studies demonstrated that inhibition of the UFD-1-NPL-4 complex triggers an aberrant immune response that is detrimental to immunocompetent worms under infection conditions but can be advantageous for immunocompromised worms.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Inhibition of the UFD-1-NPL-4 complex reduces survival of <italic>C. elegans</italic> on <italic>P. aeruginosa</italic></title>
<p>To explore the role of the UFD-1-NPL-4 complex in the innate immune response of <italic>C. elegans</italic>, we knocked down <italic>ufd-1</italic> and <italic>npl-4</italic> by RNA interference (RNAi) and studied the survival of the worms on the pathogenic bacterium <italic>P. aeruginosa</italic> PA14. Knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic> resulted in a significant reduction in the survival of N2 wild-type worms on <italic>P. aeruginosa</italic> compared to worms grown on control RNAi (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). The animals also had a reduced lifespan on <italic>Escherichia coli</italic> HT115 upon knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic> (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). The relationship between <italic>C. elegans</italic> innate immunity and longevity pathways is complex.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Inhibition of the UFD-1-NPL-4 complex reduces survival of <italic>C. elegans</italic> on <italic>P. aeruginosa</italic>.</title>
<p>(A) Representative survival plots of N2 animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi. <italic>P</italic> &lt; 0.001 for <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi compared to EV control. (B) Representative survival plots of N2 animals grown on bacteria for RNAi against <italic>ufd-1</italic> and <italic>npl-4</italic>, along with the EV control at 20°C. Day 0 represents young adults. <italic>P</italic> &lt; 0.001 for <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi compared to EV control. (C) Representative fluorescence (top) and the corresponding brightfield (bottom) images of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria. Scale bar = 200 μm. (D) Quantification of GFP levels of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each). (E) Colony-forming units (CFU) per animal of N2 worms incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria. **<italic>P</italic> &lt; 0.01 via the <italic>t</italic>-test (n = 6 biological replicates).</p></caption>
<graphic xlink:href="571255v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig1s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1—figure supplement 1.</label>
<caption><title>RNAi against <italic>ufd-1</italic> and <italic>npl-4</italic> results in the specific knockdown of their corresponding mRNAs.</title>
<p>(A)-(B) Quantitative reverse transcription-PCR for <italic>ufd-1</italic> mRNA (A) and <italic>npl-4</italic> mRNA (B) levels in N2 animals grown on the empty vector (EV) control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria at 20 °C until 1-day-old adults. ***<italic>P</italic> &lt; 0.001 and *<italic>P</italic> &lt; 0.05 via the <italic>t</italic>-test. n.s., nonsignificant (n = 4 biological replicates).</p></caption>
<graphic xlink:href="571255v2_fig1s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig1s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1—figure supplement 2.</label>
<caption><title>Effects on pharyngeal pumping and defecation are unlikely to be the reason for reduced pathogen colonization upon inhibition of the UFD-1-NPL-4 complex.</title>
<p>(A) Pharyngeal pumps per 30 seconds of N2 animals grown on <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi, along with the empty vector (EV) control RNAi. *<italic>P</italic> &lt; 0.05 via the <italic>t</italic>-test. n.s., nonsignificant (<italic>n</italic> = 45 worms each). (B) Pharyngeal pumps per 30 seconds of N2 animals grown on EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi, followed by incubation on <italic>P. aeruginosa</italic> PA14 at 25°C for 12 hours. ***<italic>P</italic> &lt; 0.001 and **<italic>P</italic> &lt; 0.01 via the <italic>t</italic>-test (<italic>n</italic> = 30 worms each). (C) The number of expulsion events observed in 15 minutes in N2 animals grown on EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test. (<italic>n</italic> = 12-13 worms each). (D) The number of expulsion events observed in 15 minutes in N2 animals grown on EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi, followed by incubation on <italic>P. aeruginosa</italic> PA14 at 25°C for 12 hours. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test. (<italic>n</italic> = 9-10 worms each).</p></caption>
<graphic xlink:href="571255v2_fig1s2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Mutants that have reduced lifespan but improved immunity have been identified (<xref ref-type="bibr" rid="c1">Amrit et al., 2019</xref>; <xref ref-type="bibr" rid="c38">Otarigho and Aballay, 2021</xref>; <xref ref-type="bibr" rid="c43">Ren and Ambros, 2015</xref>). Moreover, immunocompromised animals such as mutants of the MAP kinase pathway mediated by NSY-1/SEK-1/PMK-1 have a normal lifespan despite having significantly reduced survival on pathogenic bacteria (<xref ref-type="bibr" rid="c23">Kim et al., 2002</xref>; <xref ref-type="bibr" rid="c28">Liberati et al., 2004</xref>). Therefore, we explored the mechanisms that led to the reduced survival of <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals on <italic>P. aeruginosa</italic>. Colonization of the gut with <italic>P. aeruginosa</italic> is a major determinant of infection and survival of <italic>C. elegans</italic> under slow-killing conditions (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>; <xref ref-type="bibr" rid="c55">Tan et al., 1999</xref>). Because knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic> reduced survival on <italic>P. aeruginosa</italic>, we asked whether the animals had enhanced colonization of the gut with <italic>P. aeruginosa</italic> after <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi. Surprisingly, we observed that <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown resulted in reduced colonization of the gut with <italic>P. aeruginosa</italic> (<xref rid="fig1" ref-type="fig">Figure 1C</xref> and <xref rid="fig1" ref-type="fig">1D</xref>). To validate further, we performed the colony-forming unit assay (CFU) upon knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic>. There was a significant decline in the CFU per worm in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown worms, indicating reduced numbers of live bacteria in these worms (<xref rid="fig1" ref-type="fig">Figure 1E</xref>).</p>
<p>To confirm the specificity of the RNAi knockdowns and rule out potential off-target effects, we examined transcript levels of <italic>ufd-1</italic> and <italic>npl-4</italic> following RNAi treatment. RNAi against <italic>ufd-1</italic> significantly reduced <italic>ufd-1</italic> mRNA levels without reducing <italic>npl-4</italic> expression, while <italic>npl-4</italic> RNAi specifically downregulated <italic>npl-4</italic> transcripts with no impact on <italic>ufd-1</italic> mRNA levels (Figure 1—figure supplement 1A and B). Additionally, alignment of <italic>ufd-1</italic> and <italic>npl-4</italic> mRNA sequences against the <italic>C. elegans</italic> transcriptome revealed no significant similarity to other genes, supporting the specificity of the RNAi constructs. Moreover, the <italic>ufd-1</italic> and <italic>npl-4</italic> RNA sequences do not share significant sequence similarity. Therefore, the highly similar phenotypes observed in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals, including shortened lifespan, reduced survival on <italic>P. aeruginosa</italic>, and decreased intestinal colonization with <italic>P. aeruginosa</italic>, strongly suggest that these outcomes result from the disruption of the functional UFD-1-NPL-4 complex.</p>
<p>Reduced colonization of the gut by <italic>P. aeruginosa</italic> could be because of reduced uptake of the bacterium in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals. The rate of pharyngeal pumping is an indicator of the uptake of bacterial food. We studied whether inhibition of <italic>ufd-1</italic> and <italic>npl-4</italic> affected the pharyngeal pumping rate. The knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic> did not affect the pharyngeal pumping rate (Figure 1—figure supplement 2A), indicating that the reduced colonization was unlikely due to the reduced uptake of bacteria. Next, we tested whether exposure to <italic>P. aeruginosa</italic> affected the pharyngeal pumping in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals. Exposure to <italic>P. aeruginosa</italic> for 12 hours resulted in a minimal reduction in the pharyngeal pumping rate in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals compared to control animals (Figure 1—figure supplement 2B). These results suggested that the reduced colonization of <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals by <italic>P. aeruginosa</italic> was unlikely because of the reduced uptake of bacteria.</p>
<p>The clearance of intestinal contents through the defecation motor program (DMP) is known to influence gut colonization by <italic>P. aeruginosa</italic> in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>). It is therefore conceivable that knockdown of the UFD-1-NPL-4 complex might increase defecation frequency, thereby promoting the physical expulsion of bacteria and resulting in reduced gut colonization. To test this possibility, we measured DMP rates in animals subjected to <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi. Contrary to this hypothesis, both <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals exhibited a significant reduction in defecation frequency compared to control RNAi-treated animals (Figure 1—figure supplement 2C). This reduction in DMP rate persisted even after 12 hours of exposure to <italic>P. aeruginosa</italic> (Figure 1—figure supplement 2D). Thus, the change in the DMP rate in <italic>ufd-1</italic> and <italic>npl-4</italic> knockdown animals is unlikely to be the reason for the reduced gut colonization by <italic>P. aeruginosa</italic>.</p>
<p>Taken together, these results suggested that the inhibition of the UFD-1-NPL-4 complex reduced the survival of <italic>C. elegans</italic> on <italic>P. aeruginosa</italic> despite diminished colonization of the gut with the bacterium. Because <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi led to very similar phenotypes, we further used only <italic>ufd-1</italic> RNAi to decipher the mechanisms of reduced survival and diminished colonization on <italic>P. aeruginosa</italic>.</p>
</sec>
<sec id="s2b">
<title>Reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown is independent of the ER-UPR pathways</title>
<p>Knockdown of the UFD-1-NPL-4 complex is known to cause ER stress, resulting in the upregulation of the ER-UPR pathways (<xref ref-type="bibr" rid="c35">Mouysset et al., 2006</xref>; <xref ref-type="bibr" rid="c47">Sasagawa et al., 2007</xref>). Because ER stress and UPR pathways modulate innate immunity (<xref ref-type="bibr" rid="c45">Richardson et al., 2010</xref>; <xref ref-type="bibr" rid="c53">Singh and Aballay, 2017</xref>; <xref ref-type="bibr" rid="c54">Sun et al., 2012</xref>), we asked whether the ER-UPR pathways were involved in the regulation of survival and colonization of <italic>ufd-1</italic> knockdown animals on <italic>P. aeruginosa</italic>. We studied the survival and colonization of mutants of different ER-UPR pathways, including <italic>xbp-1(tm2482)</italic>, <italic>atf-6(ok551)</italic>, and <italic>pek-1(ok275)</italic> on <italic>P. aeruginosa</italic>. The survival of <italic>xbp-1(tm2482)</italic> animals upon <italic>ufd-1</italic> knockdown was indistinguishable from that of the control animals (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). However, <italic>ufd-1</italic> knockdown resulted in significantly reduced gut colonization with <italic>P. aeruginosa</italic> in <italic>xbp-1(tm2482)</italic> animals (<xref rid="fig2" ref-type="fig">Figure 2B</xref> and <xref rid="fig2" ref-type="fig">2C</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown is independent of the ER-UPR pathways.</title>
<p>(A) Representative survival plots of <italic>xbp-1(tm2482)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control and <italic>ufd-1</italic> RNAi. The difference between the EV and <italic>ufd-1</italic> RNAi survival plots is nonsignificant. (B) Representative fluorescence images of <italic>xbp-1(tm2482)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (C) Quantification of GFP levels of <italic>xbp-1(tm2482)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. **<italic>P</italic> &lt; 0.01 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each). (D) Representative survival plots of <italic>atf-6(ok551)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the EV control and <italic>ufd-1</italic> RNAi. <italic>P</italic> &lt; 0.001. (E) Representative fluorescence images of <italic>atf-6(ok551)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (F) Quantification of GFP levels of <italic>atf-6(ok551)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each). (G) Representative survival plots of <italic>pek-1(ok275)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the EV control and <italic>ufd-1</italic> RNAi. <italic>P</italic> &lt; 0.001. (H) Representative fluorescence images of <italic>pek-1(ok275)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (I) Quantification of GFP levels of <italic>pek-1(ok275)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 24–25 worms each).</p></caption>
<graphic xlink:href="571255v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2—figure supplement 1.</label>
<caption><title>Reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown is independent of the XBP-1 ER-UPR pathway.</title>
<p>(A) Representative survival plots of AGD927 (neuronally overexpressing the constitutively active spliced form of XBP-1, XBP-1s) animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control and <italic>ufd-1</italic> RNAi. <italic>P</italic> &lt; 0.001. (B) Representative fluorescence images of AGD927 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. The red fluorescence in the pharynx region is from the <italic>myo-2p::tdTomato</italic> coinjection marker. Scale bar = 200 μm. (C) Quantification of GFP levels of AGD927 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 30 worms each).</p></caption>
<graphic xlink:href="571255v2_fig2s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To further examine the role of XBP-1 in this context, we assessed the effect of <italic>ufd-1</italic> knockdown in animals neuronally overexpressing the constitutively active spliced form of XBP-1 (XBP-1s), which has been previously associated with enhanced longevity (<xref ref-type="bibr" rid="c56">Taylor and Dillin, 2013</xref>). Knockdown of <italic>ufd-1</italic> resulted in the reduced survival of XBP-1s-overexpressing animals on <italic>P. aeruginosa</italic>, despite a concurrent decrease in bacterial colonization of the gut (Figure 2—figure supplement 1A-C). This indicated that the XBP-1 pathway was not required for the reduced <italic>P. aeruginosa</italic> colonization of <italic>ufd-1</italic> knockdown animals.</p>
<p>The <italic>atf-6(ok551)</italic> animals exhibited reduced survival on <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> RNAi compared to the control RNAi (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). Similar to N2, <italic>ufd-1</italic> knockdown resulted in reduced colonization of the gut with <italic>P. aeruginosa</italic> in <italic>atf-6(ok551)</italic> animals (<xref rid="fig2" ref-type="fig">Figure 2E</xref> and <xref rid="fig2" ref-type="fig">2F</xref>). The <italic>pek-1(ok275)</italic> animals exhibited similar phenotypes of reduced survival and diminished colonization on <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown (<xref rid="fig2" ref-type="fig">Figure 2G-I</xref>). These results indicated that the reduced colonization and survival of <italic>ufd-1</italic> knockdown animals on <italic>P. aeruginosa</italic> were independent of the ER-UPR pathways.</p>
</sec>
<sec id="s2c">
<title>Reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown is independent of the major immunity pathways</title>
<p>Next, we tested whether any of the immunity pathways were involved in regulating the reduced colonization by <italic>ufd-1</italic> knockdown. To this end, we studied the survival and colonization of mutants of different immunity pathways on <italic>P. aeruginosa</italic> upon knockdown of <italic>ufd-1</italic>. The <italic>pmk-1(km25)</italic> animals, which are part of a MAP kinase pathway mediated by NSY-1/SEK-1/PMK-1 (<xref ref-type="bibr" rid="c23">Kim et al., 2002</xref>), had a similar survival rate on control and <italic>ufd-1</italic> RNAi (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). However, <italic>ufd-1</italic> knockdown significantly reduced colonization in <italic>pmk-1(km25)</italic> animals (<xref rid="fig3" ref-type="fig">Figure 3B</xref> and <xref rid="fig3" ref-type="fig">3C</xref>). This indicated that the <italic>pmk-1</italic> pathway is unlikely to be involved in mediating <italic>ufd-1</italic> knockdown effects, and the similar survival rate of control and <italic>ufd-1</italic> RNAi animals is merely coincidental. Indeed, a mutant of the upstream regulator of the PMK-1 pathway, the Toll/interleukin-1 receptor domain protein (TIR-1) (<xref ref-type="bibr" rid="c28">Liberati et al., 2004</xref>; <xref ref-type="bibr" rid="c40">Peterson et al., 2022</xref>), exhibited phenotypes similar to <italic>pmk-1(km25)</italic> animals ((Figure 3—figure supplement 1A-C).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown is independent of the major immunity pathways.</title>
<p>(A) Representative survival plots of <italic>pmk-1(km25)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control and <italic>ufd-1</italic> RNAi. The difference between the EV and <italic>ufd-1</italic> RNAi survival plots is nonsignificant. (B) Representative fluorescence images of <italic>pmk-1(km25)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (C) Quantification of GFP levels of <italic>pmk-1(km25)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each). (D) Representative survival plots of <italic>dbl-1(nk3)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the EV control and <italic>ufd-1</italic> RNAi. The difference between the EV and <italic>ufd-1</italic> RNAi survival plots is nonsignificant. (E) Representative fluorescence images of <italic>dbl-1(nk3)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (F) Quantification of GFP levels of <italic>dbl-1(nk3)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each). (G) Representative survival plots of <italic>hlh-30(tm1978)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the EV control and <italic>ufd-1</italic> RNAi. <italic>P</italic> &lt; 0.001. (H) Representative fluorescence images of <italic>hlh-30(tm1978)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (I) Quantification of GFP levels of <italic>hlh-30(tm1978)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 16 worms each).</p></caption>
<graphic xlink:href="571255v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3—figure supplement 1.</label>
<caption><title>Reduced gut colonization upon <italic>ufd-1</italic> knockdown is independent of the <italic>tir-1</italic> immunity pathway.</title>
<p>(A) Representative survival plots of <italic>tir-1(qd4)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control and <italic>ufd-1</italic> RNAi. The difference between the EV and <italic>ufd-1</italic> RNAi survival plots is nonsignificant. (B) Representative fluorescence images of <italic>tir-1(qd4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (C) Quantification of GFP levels of <italic>tir-1(qd4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 19-20 worms each).</p></caption>
<graphic xlink:href="571255v2_fig3s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The mutants of the TGF-β/DBL-1 (<xref ref-type="bibr" rid="c29">Mallo et al., 2002</xref>) and TFEB/HLH-30 (<xref ref-type="bibr" rid="c61">Visvikis et al., 2014</xref>) immunity pathways also exhibited phenotypes similar to <italic>pmk-1(km25)</italic> animals.</p>
<p>The knockdown of <italic>ufd-1</italic> resulted in significantly reduced colonization of <italic>dbl-1(nk3)</italic> and <italic>hlh-30(tm1978)</italic> animals without affecting their survival on <italic>P. aeruginosa</italic> (<xref rid="fig3" ref-type="fig">Figure 3D-I</xref>). These results indicated that the reduced colonization with <italic>P. aeruginosa</italic> upon <italic>ufd-1</italic> knockdown was independent of these immunity pathways.</p>
</sec>
<sec id="s2d">
<title>Inhibition of the UFD-1-NPL-4 complex improves survival of severely immunocompromised <italic>C. elegans</italic> on <italic>P. aeruginosa</italic></title>
<p>Knockdown of <italic>ufd-1</italic> reduced colonization in wild-type animals as well as mutants of ER-UPR and innate immunity pathways. Interestingly, despite variable survival rates on control RNAi, all strains had similar survival rates upon knockdown of <italic>ufd-1</italic> (Figure 4—figure supplement 1). We reasoned that <italic>ufd-1</italic> knockdown might lead to an aberrant immune response that results in diminished gut colonization by <italic>P. aeruginosa</italic> and reduces the survival of healthy but not immunocompromised animals. If this were the case, knockdown of the UFD-1-NPL-4 complex might improve the survival of severely immunocompromised animals by activating a compensatory immune response. In <italic>C. elegans</italic>, the canonical p38 MAP kinase signaling cascade consists of NSY-1 (ASK1 MAPKKK), SEK-1 (MKK3/MKK6 MAPKK), and PMK-1 (p38 MAPK) (<xref ref-type="bibr" rid="c23">Kim et al., 2002</xref>). Compared to <italic>pmk-1</italic> knockout, the knockout of <italic>sek-1</italic> leads to more severe effects on survival upon infection with <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="c31">Meng et al., 2021</xref>). Indeed, we observed that most of the <italic>sek-1(km4)</italic> animals on control RNAi died within 24 hours of exposure to <italic>P. aeruginosa</italic> (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). Importantly, the knockdown of <italic>ufd-1</italic> resulted in a significant improvement in the survival of <italic>sek-1(km4)</italic> animals (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). To test whether the improved survival of <italic>sek-1(km4)</italic> animals upon the knockdown of <italic>ufd-1</italic> was because of inhibition of the UFD-1-NPL-4 complex, we studied the survival of <italic>sek-1(km4)</italic> animals upon <italic>npl-4</italic> RNAi. The knockdown of <italic>npl-4</italic> also resulted in significantly enhanced survival of <italic>sek-1(km4)</italic> animals (<xref rid="fig4" ref-type="fig">Figure 4A</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Inhibition of the UFD-1-NPL-4 complex improves survival of severely immunocompromised <italic>C. elegans</italic> on <italic>P. aeruginosa</italic>.</title>
<p>(A) Representative survival plots of <italic>sek-1(km4)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi. <italic>P</italic> &lt; 0.001 for <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi compared to EV control. (B) Representative fluorescence images of <italic>sek-1(km4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria. Scale bar = 200 μm. (C) Quantification of GFP levels of <italic>sek-1(km4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the EV control, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 19–20 worms each). (D) Representative survival plots of <italic>sek-1(km4)</italic> animals grown on bacteria for RNAi against <italic>ufd-1</italic> and <italic>npl-4</italic> along with the EV control at 20°C. Day 0 represents young adults. <italic>P</italic> &lt; 0.001 for <italic>ufd-1</italic> and <italic>npl-4</italic> RNAi compared to EV control. (E) Representative survival plots of <italic>dbl-1(nk3);pmk-1(km25)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the EV control and <italic>ufd-1</italic> RNAi. <italic>P</italic> &lt; 0.001. (F) Representative fluorescence images of <italic>dbl-1(nk3);pmk-1(km25)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm. (G) Quantification of GFP levels of <italic>dbl-1(nk3);pmk-1(km25)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the EV control and <italic>ufd-1</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 24 worms each).</p></caption>
<graphic xlink:href="571255v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4—figure supplement 1.</label>
<caption><title>Knockdown of <italic>ufd-1</italic> dictates survival of different worm strains on <italic>P. aeruginosa</italic>.</title>
<p>(A) Representative survival plots of worm strains on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the empty vector (EV) control RNAi. (B) Representative survival plots of worm strains on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with <italic>ufd-1</italic> RNAi. The data in (A) and (B) are pooled from the data from <xref ref-type="fig" rid="fig1">Figures 1</xref>-<xref ref-type="fig" rid="fig3">3</xref> and Figure 3—figure supplement 1.</p></caption>
<graphic xlink:href="571255v2_fig4s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Knockdown of both <italic>ufd-1</italic> and <italic>npl-4</italic> in <italic>sek-1(km4)</italic> animals resulted in reduced gut colonization by <italic>P. aeruginosa</italic> compared to control RNAi (<xref rid="fig4" ref-type="fig">Figure 4B</xref> and <xref rid="fig4" ref-type="fig">4C</xref>). Because <italic>sek-1(km4)</italic> animals do not have a reduced lifespan on <italic>E. coli</italic> diet (<xref ref-type="bibr" rid="c23">Kim et al., 2002</xref>), we studied how inhibition of the UFD-1-NPL-4 complex affected the lifespan of <italic>sek-1(km4)</italic> animals. We reasoned that if the inhibition of the UFD-1-NPL-4 complex resulted in a heightened aberrant immune response, it should result in a reduced lifespan of <italic>sek-1(km4)</italic> animals on <italic>E. coli</italic> despite improving their survival on <italic>P. aeruginosa</italic>. Indeed, the knockdown of <italic>ufd-1</italic> and <italic>npl-4</italic> significantly reduced the lifespan of <italic>sek-1(km4)</italic> animals on <italic>E. coli</italic> HT115 (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). These results suggested that inhibition of the UFD-1-NPL-4 complex led to an aberrant immune response, which improves survival of severely immunocompromised animals under infection conditions but reduces survival of such animals under non-infection conditions.</p>
<p>To further establish that inhibition of the UFD-1-NPL-4 complex resulted in the improved survival of severely immunocompromised animals on <italic>P. aeruginosa</italic>, we created a <italic>dbl-1(nk3);pmk-1(km25)</italic> double mutant. The TGF-β/DBL-1 and p38 MAPK/PMK-1 control immunity via parallel pathways (<xref ref-type="bibr" rid="c50">Singh and Aballay, 2020</xref>), and the <italic>dbl-1(nk3);pmk-1(km25)</italic> animals show reduced survival on <italic>P. aeruginosa</italic> compared to individual mutants (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). The knockdown of <italic>ufd-1</italic> resulted in improved survival (<xref rid="fig4" ref-type="fig">Figure 4E</xref>) and reduced colonization (<xref rid="fig4" ref-type="fig">Figure 4F</xref> and <xref rid="fig4" ref-type="fig">4G</xref>) of <italic>dbl-1(nk3);pmk-1(km25)</italic> animals on <italic>P. aeruginosa</italic>. Taken together, these data showed that inhibition of the UFD-1-NPL-4 complex improved the survival of severely immunocompromised animals on <italic>P. aeruginosa</italic>.</p>
</sec>
<sec id="s2e">
<title>Knockdown of <italic>ufd-1</italic> results in the upregulation of protease and intracellular pathogen response genes</title>
<p>To understand the molecular basis of the phenotypes observed upon knockdown of <italic>ufd-1</italic>, we used RNA sequencing to focus on transcriptional changes induced by <italic>ufd-1</italic> RNAi. Of the 439 differentially regulated genes, 319 were upregulated, while 120 were downregulated (<xref rid="fig5" ref-type="fig">Figure 5A</xref> and Table S1). Gene ontology (GO) analysis for biological processes for upregulated genes showed enrichment for innate immune response (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). As <italic>ufd-1</italic> is required for ERAD, different ER-UPR pathway genes were also enriched in the upregulated genes. In addition, enrichment for proteolysis genes was also observed. GO analysis for cellular components and molecular function for upregulated genes showed enrichment for lysosomes and peptidase activities, respectively (<xref rid="fig5" ref-type="fig">Figure 5C</xref> and <xref rid="fig5" ref-type="fig">5D</xref>). These results indicated that the knockdown of <italic>ufd-1</italic> might result in increased proteolysis activities via lysosomes. GO analysis for biological processes for downregulated genes also showed enrichment for innate immune response (Figure 5—figure supplement 1). This indicated that <italic>ufd-1</italic> might be required for the expression of some innate immune response genes. GO analysis for cellular components and molecular function for downregulated genes primarily identified functions related to nucleosomes (Figure 5—figure supplement 1B and 1C). Indeed, UFD-1 is known to localize to the nucleus and is required for chromatin stability (<xref ref-type="bibr" rid="c34">Mouysset et al., 2008</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Knockdown of <italic>ufd-1</italic> results in the upregulation of protease and intracellular pathogen response genes.</title>
<p>(A) Volcano plot of upregulated and downregulated genes in <italic>ufd-1</italic> RNAi versus empty vector (EV) control RNAi N2 animals. Orange and green dots represent significantly upregulated and downregulated genes, respectively, while the grey dots represent the genes that are not differentially regulated. (B)-(D) Gene ontology enrichment analysis for <italic>ufd-1</italic> RNAi upregulated genes for biological processes (B), cellular component (C), and molecular function (D). (E) Venn diagram showing the overlap between genes upregulated upon <italic>ufd-1</italic> RNAi and upregulated upon <italic>Nematocida parisii</italic> infection (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>). The <italic>P</italic>-value for the overlap between the data is 8.2×10<sup>-110</sup>. (F) Venn diagram showing the overlap between genes upregulated upon <italic>ufd-1</italic> RNAi and upregulated upon Orsay virus infection (<xref ref-type="bibr" rid="c46">Sarkies et al., 2013</xref>). The <italic>P</italic>-value for the overlap between the data is 2.7×10<sup>-62</sup>.</p></caption>
<graphic xlink:href="571255v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig5s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5—figure supplement 1.</label>
<caption><title>Gene ontology enrichment analysis for <italic>ufd-1</italic> RNAi downregulated genes.</title>
<p>(A)-(C) Gene ontology enrichment analysis for <italic>ufd-1</italic> RNAi downregulated genes for biological processes (A), cellular component (B), and molecular function (C).</p></caption>
<graphic xlink:href="571255v2_fig5s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Next, we compared the upregulated genes with previously published gene expression data using WormExp (<xref ref-type="bibr" rid="c65">Yang et al., 2016b</xref>). Interestingly, we observed that the <italic>ufd-1</italic> RNAi upregulated genes had a very high overlap with genes upregulated by intracellular pathogens <italic>Nematocida parisii</italic> (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>) (<xref rid="fig5" ref-type="fig">Figure 5E</xref>) and Orsay virus (<xref ref-type="bibr" rid="c46">Sarkies et al., 2013</xref>) (<xref rid="fig5" ref-type="fig">Figure 5F</xref>). Infection with the intracellular pathogens <italic>N. parisii</italic> and Orsay virus results in the activation of an intracellular pathogen response (IPR), which includes several <italic><underline>p</underline></italic>rotein containing <italic><underline>ALS</underline></italic>2CR12 signature (<italic>pals</italic>) genes as well as genes involved in proteolysis (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>; <xref ref-type="bibr" rid="c46">Sarkies et al., 2013</xref>). Indeed, <italic>ufd-1</italic> RNAi resulted in the upregulation of several <italic>pals</italic> and proteolysis genes (<xref ref-type="supplementary-material" rid="tbls1">Table S1</xref>). These results indicated that the knockdown of <italic>ufd-1</italic> might mimic an intracellular pathogen infection and result in the activation of the IPR.</p>
</sec>
<sec id="s2f">
<title>GATA transcription factor ELT-2 mediates the <italic>ufd-1</italic> knockdown phenotypes</title>
<p>To identify the genes downstream of <italic>ufd-1</italic> knockdown that were responsible for reduced colonization, we knocked down individual genes that were upregulated upon <italic>ufd-1</italic> RNAi and studied colonization of the gut with <italic>P. aeruginosa</italic>. We hypothesized that the reduced colonization might be because of increased expression of proteolysis genes. Therefore, we knocked down the proteolysis genes that were upregulated by <italic>ufd-1</italic> RNAi. Knockdown of the protease genes <italic>cpr-1</italic>, <italic>asp-12</italic>, and Y71H2AR.25 led to a significant increase in colonization in <italic>ufd-1</italic> knockdown animals (Figure 6—figure supplement 1A), suggesting that increased expression of protease genes might be responsible for reduced colonization. Because <italic>ufd-1</italic> knockdown also resulted in the upregulation of several <italic>pals</italic> genes, which are part of the IPR, we next targeted the <italic>pals</italic> genes upregulated by <italic>ufd-1</italic> RNAi. Knockdown of the <italic>pals</italic> genes, <italic>pals-9</italic>, <italic>pals-14</italic>, <italic>pals-16</italic>, <italic>pals-17</italic>, and <italic>pals-29</italic>, resulted in a significant increase in colonization in <italic>ufd-1</italic> knockdown animals (Figure 6—figure supplement 1B). These results indicated that some of the proteases and IPR genes are involved in the regulation of colonization in <italic>ufd-1</italic> knockdown animals. It is also likely that these genes function redundantly, and multiple genes contribute to the observed phenotype.</p>
<p>To identify the transcription factors that regulate the diminished colonization and reduced survival phenotype of <italic>ufd-1</italic> knockdown, we carried out transcription factor enrichment analysis for upregulated genes using WormExp. The <italic>ufd-1</italic> RNAi upregulated genes substantially overlapped with the genes regulated by the GATA transcription factor ELT-2 (<xref ref-type="bibr" rid="c11">Dineen et al., 2018</xref>; <xref ref-type="bibr" rid="c30">Mann et al., 2016</xref>) (<xref rid="fig6" ref-type="fig">Figure 6A</xref> and <xref rid="fig6" ref-type="fig">6B</xref>). Indeed, ELT-2 is known to regulate the expression of protease and <italic>pals</italic> genes (<xref ref-type="bibr" rid="c30">Mann et al., 2016</xref>). To assess whether ELT-2 contributes to the phenotypes associated with <italic>ufd-1</italic> knockdown, we conducted double RNAi experiments in N2 animals targeting both <italic>ufd-1</italic> and <italic>elt-2</italic> and examined <italic>P. aeruginosa</italic> colonization. The double knockdown of <italic>ufd-1</italic> and <italic>elt-2</italic> did not compromise RNAi efficiency, as evidenced by significantly reduced <italic>ufd-1</italic> mRNA levels and diminished ELT-2::GFP signal (Figure 6—figure supplement 2A and B). Importantly, knockdown of <italic>elt-2</italic> resulted in a significant increase in <italic>P. aeruginosa</italic> colonization in <italic>ufd-1</italic> knockdown animals (<xref rid="fig6" ref-type="fig">Figure 6C</xref> and <xref rid="fig6" ref-type="fig">6D</xref>). Similar to N2 worms, the knockdown of <italic>elt-2</italic> resulted in a significant increase in <italic>P. aeruginosa</italic> colonization in <italic>ufd-1</italic> knockdown <italic>sek-1(km4)</italic> animals (<xref rid="fig6" ref-type="fig">Figure 6E</xref> and <xref rid="fig6" ref-type="fig">6F</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>GATA transcription factor ELT-2 mediates the <italic>ufd-1</italic> knockdown phenotypes.</title>
<p>(A) Venn diagram showing the overlap between genes upregulated upon <italic>ufd-1</italic> RNAi and upregulated in wt versus <italic>elt-2</italic>(-) larvae (<xref ref-type="bibr" rid="c11">Dineen et al., 2018</xref>). The <italic>P</italic>-value for the overlap between the data is 9.5×10<sup>-52</sup>. (B) Venn diagram showing the overlap between genes upregulated upon <italic>ufd-1</italic> RNAi and the low-complexity ELT-2 target genes (<xref ref-type="bibr" rid="c30">Mann et al., 2016</xref>). The <italic>P</italic>-value for the overlap between the data is 1.5×10<sup>-34</sup>. (C) Representative fluorescence (top) and the corresponding brightfield (bottom) images of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the <italic>gfp</italic> RNAi (GFP) control, <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria (see Methods for the details). Scale bar = 200 μm. (D) Quantification of GFP levels of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on the <italic>gfp</italic> RNAi control, <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 28-30 worms each). (E) Representative fluorescence (top) and the corresponding brightfield (bottom) images of <italic>sek-1(km4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the <italic>gfp</italic> RNAi control, <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria. Scale bar = 200 μm. (F) Quantification of GFP levels of <italic>sek-1(km4)</italic> animals incubated on <italic>P. aeruginosa</italic>-GFP for 12 hours at 25°C after growth on the <italic>gfp</italic> RNAi control, <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 30-31 worms each). (G) Representative survival plots of <italic>sek-1(km4)</italic> animals on <italic>P. aeruginosa</italic> PA14 at 25°C after treatment with the <italic>gfp</italic> RNAi control, <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria. <italic>P</italic> &lt; 0.001 for <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi compared to GFP+<italic>ufd-1</italic> RNAi.</p></caption>
<graphic xlink:href="571255v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6—figure supplement 1.</label>
<caption><title>Role of protease or intracellular pathogen response genes in reduced colonization of <italic>ufd-1</italic> RNAi animals.</title>
<p>(A) Quantification of GFP levels of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on indicated RNAi bacteria. <italic>P</italic>-values in comparison to the <italic>gfp</italic> RNAi (GFP) and GFP+<italic>ufd-1</italic> RNAi are indicated. ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, and *<italic>P</italic> &lt; 0.05 via the <italic>t</italic>-test. n.s., nonsignificant (<italic>n</italic> = 26-30 worms each). (B) Quantification of GFP levels of N2 animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on indicated RNAi bacteria. <italic>P</italic>-values in comparison to the <italic>gfp</italic> RNAi (GFP) and GFP+<italic>ufd-1</italic> RNAi are indicated. ***<italic>P</italic> &lt; 0.001, **<italic>P</italic> &lt; 0.01, and *<italic>P</italic> &lt; 0.05 via the <italic>t</italic>-test. n.s., nonsignificant (<italic>n</italic> = 19-20 worms each).</p></caption>
<graphic xlink:href="571255v2_fig6s1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6—figure supplement 2.</label>
<caption><title>Double RNAi does not impact <italic>ufd-1</italic> or <italic>elt-2</italic> mRNA knockdown.</title>
<p>(A) Quantitative reverse transcription-PCR for <italic>ufd-1</italic> mRNA levels in N2 animals grown on the <italic>gfp</italic> RNAi control (GFP), <italic>ufd-1</italic>, GFP+<italic>elt-2</italic>, GFP+<italic>ufd-1</italic>, and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi bacteria. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test. n.s., nonsignificant (n = 4 biological replicates). (B) Representative fluorescence and corresponding brightfield images of ELT-2::GFP worms grown on the control empty vector (EV), <italic>elt-2</italic>, and <italic>elt-2</italic>+<italic>ufd-1</italic> RNAi bacteria. Scale bar = 200 μm.</p></caption>
<graphic xlink:href="571255v2_fig6s2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6—figure supplement 3.</label>
<caption><title>ELT-2 overexpression partly recapitulates the <italic>ufd-1</italic> knockdown phenotypes.</title>
<p>(A) Representative fluorescence images of N2 and ELT-2 overexpression (<italic>elt-2</italic>_OE) animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on <italic>E. coli</italic> OP50. Scale bar = 200 μm. (B) Quantification of GFP levels of N2 and <italic>elt-2</italic>_OE animals incubated on <italic>P. aeruginosa</italic>-GFP for 24 hours at 25°C after growth on <italic>E. coli</italic> OP50. ***<italic>P</italic> &lt; 0.001 via the <italic>t</italic>-test (<italic>n</italic> = 30 worms each). (C) Representative survival plots of N2 and <italic>elt-2</italic>_OE animals on <italic>P. aeruginosa</italic> PA14 at 25°C after growth on <italic>E. coli</italic> OP50. The difference between the N2 and <italic>elt-2</italic>_OE survival plots is nonsignificant.</p></caption>
<graphic xlink:href="571255v2_fig6s3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Because <italic>ufd-1</italic> knockdown in <italic>sek-1(km4)</italic> worms improves their survival on <italic>P. aeruginosa</italic> (<xref rid="fig4" ref-type="fig">Figure 4A</xref>), we also studied whether <italic>elt-2</italic> was responsible for the increased survival of <italic>sek-1(km4)</italic> worms upon <italic>ufd-1</italic> knockdown. Indeed, the knockdown of <italic>elt-2</italic> abolished the beneficial effects of <italic>ufd-1</italic> knockdown on the survival of <italic>sek-1(km4)</italic> worms on <italic>P. aeruginosa</italic> (<xref rid="fig6" ref-type="fig">Figure 6G</xref>).</p>
<p>To determine whether ELT-2 activation alone is sufficient to recapitulate the phenotypes observed upon UFD-1-NPL-4 complex inhibition, we analyzed animals overexpressing ELT-2. Similar to <italic>ufd-1</italic> knockdown, ELT-2 overexpression led to a significant reduction in the colonization of the gut by <italic>P. aeruginosa</italic> (Figure 6—figure supplement 3A and 3B). However, overexpression of ELT-2 did not alter the survival of worms on <italic>P. aeruginosa</italic> (Figure 6—figure supplement 3C). Taken together, these findings suggest that the phenotypes triggered by disruption of the UFD-1-NPL-4 complex are partially mediated by ELT-2. However, additional pathways, yet to be identified, likely cooperate with ELT-2 to regulate both pathogen resistance and host survival.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In this study, we show that inhibition of the UFD-1-NPL-4 complex leads to an aberrant immune response in <italic>C. elegans</italic>. Suppression of this complex leads to reduced gut colonization with <italic>P. aeruginosa</italic> in wild-type animals as well as mutants of different ER-UPR and immunity pathways. Despite the reduction in pathogen load, the wild-type animals exhibit reduced survival, indicative of a detrimental immune response. However, immunocompromised mutants, which have significantly reduced survival on pathogenic bacteria, exhibit reduced colonization and improved survival on inhibition of the UFD-1-NPL-4 complex. This indicates that the immune response activated by the inhibition of the UFD-1-NPL-4 complex compensates for the dampened immune response of the immunocompromised mutants. Despite beneficial effects on the survival on pathogenic bacteria, inhibition of the UFD-1-NPL-4 complex leads to adverse effects on the lifespan of immunocompromised mutants. This is because the immunocompromised mutants have a normal lifespan on nonpathogenic bacteria, and the aberrant immune response becomes detrimental on such bacterial diets.</p>
<p>Previous studies have shown that hyperactivation of immune pathways can negatively affect organismal development. For example, sustained activation of the p38 MAPK pathway impairs development in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="c7">Cheesman et al., 2016</xref>; <xref ref-type="bibr" rid="c24">Kim et al., 2016</xref>), and excessive activation of the IPR also leads to developmental defects (<xref ref-type="bibr" rid="c25">Lažetić et al., 2023</xref>). Similar to our current study, recent work has demonstrated that heightened immune responses can reduce gut pathogen load while paradoxically decreasing host survival during infection (<xref ref-type="bibr" rid="c15">Ghosh and Singh, 2024</xref>; <xref ref-type="bibr" rid="c40">Peterson et al., 2022</xref>). However, our study uniquely shows that while such heightened immune responses are detrimental to immunocompetent animals, they can be beneficial in the context of immunodeficiency.</p>
<p>We find that the knockdown of <italic>ufd-1</italic> led to the upregulation of several genes that are part of the IPR activated by intracellular pathogens <italic>N. parisii</italic> and Orsay virus (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>; <xref ref-type="bibr" rid="c46">Sarkies et al., 2013</xref>). The ubiquitination components have been shown to be required for targeting the intracellular pathogen <italic>N. parisii</italic> (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>). As a counterattack, the pathogen probably targets the ubiquitin-proteasome system of the host (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>). Therefore, the intracellular pathogens <italic>N. parisii</italic> and Orsay virus might activate the IPR by inhibiting the ubiquitin-proteasome system (<xref ref-type="bibr" rid="c2">Bakowski et al., 2014</xref>; <xref ref-type="bibr" rid="c42">Reddy et al., 2019</xref>). We show that inhibition of the UFD-1-NPL-4 complex activates the IPR. The activation of the IPR by the inhibition of the UFD-1-NPL-4 complex could be a consequence of the direct inhibition of this complex itself or an indirect perturbation of the proteasomal degradation of proteins. In future studies, it will be intriguing to decipher whether intracellular pathogens target the UFD-1-NPL-4 complex.</p>
<p>We demonstrate that the GATA transcription factor ELT-2 mediated the aberrant response downstream of the inhibition of the UFD-1-NPL-4 complex. ELT-2 is known to be required for defense as well as recovery responses against a variety of pathogens (<xref ref-type="bibr" rid="c18">Head and Aballay, 2014</xref>; <xref ref-type="bibr" rid="c48">Shapira et al., 2006</xref>; <xref ref-type="bibr" rid="c64">Yang et al., 2016a</xref>). Previous studies have reported interactions of ELT-2 with the proteasome system. The non-proteolytic activity of the 19S proteasome subunit RPT-6 was shown to regulate the ELT-2-mediated immune response (<xref ref-type="bibr" rid="c37">Olaitan and Aballay, 2018</xref>). Another study showed that the bacterial pathogen <italic>Burkholderia pseudomallei</italic> leads to the downregulation of ELT-2 target genes (<xref ref-type="bibr" rid="c26">Lee et al., 2013</xref>). It was demonstrated that the downregulation of ELT-2 targets was associated with the degradation of ELT-2 protein by the host ubiquitin-proteasome system. Therefore, multiple mechanisms could regulate the activity of ELT-2 via the ubiquitin-proteasome system. In future studies, it will be interesting to study how inhibition of the UFD-1-NPL-4 complex modulates the activities of the GATA transcription factor ELT-2.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<table-wrap id="utbl1" orientation="portrait" position="float">
<graphic xlink:href="571255v2_utbl1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="571255v2_utbl1a.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="571255v2_utbl1b.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="571255v2_utbl1c.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<sec id="s4a">
<title>Bacterial strains</title>
<p>The following bacterial strains were used in the current study: <italic>Escherichia coli</italic> OP50, <italic>E. coli</italic> HT115(DE3), <italic>Pseudomonas aeruginosa</italic> PA14, and <italic>P. aeruginosa</italic> PA14 expressing green fluorescent protein (<italic>P. aeruginosa</italic> PA14-GFP). The cultures of <italic>E. coli</italic> OP50, <italic>E. coli</italic> HT115(DE3), and <italic>P. aeruginosa</italic> PA14 were grown in Luria-Bertani (LB) broth at 37°C. The <italic>P. aeruginosa</italic> PA14-GFP cultures were grown in LB broth with 50 µg/mL kanamycin at 37°C.</p>
</sec>
<sec id="s4b">
<title><italic>C. elegans</italic> strains and growth conditions</title>
<list list-type="order">
<list-item><p><italic>C. elegans</italic> hermaphrodites were maintained at 20°C on nematode growth medium (NGM) plates seeded with <italic>E. coli</italic> OP50 as the food source unless otherwise indicated. Bristol N2 was used as the wild-type control unless otherwise indicated. The following strains were used in the study: KU4 <italic>sek-1(km4),</italic> KU25 <italic>pmk-1(km25),</italic> NU3 <italic>dbl-1(nk3),</italic> JIN1375 <italic>hlh-30(tm1978), xbp-1(tm2482),</italic> RB545 <italic>pek-1(ok275),</italic> RB772 <italic>atf-6(ok551),</italic> and RB1085 <italic>tir-1(qd4)</italic>, AGD927 <italic>uthIs270 [rab-3p::xbp-1s (constitutively active) + myo-2p::tdTomato]</italic>, and SD1949 <italic>glo-4(ok623);gaIs290 [elt-2::TY1::EGFP::3xFLAG(92C12) + unc-119(+)]</italic>. Some of the strains were obtained from the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN). The <italic>dbl-1(nk3);pmk-1(km25)</italic> strain was obtained by a standard genetic cross.</p></list-item>
</list>
</sec>
<sec id="s4c">
<title>Construction of the <italic>npl-4</italic> RNAi clone</title>
<p>The 1581-base-pair full-length cDNA of <italic>npl-4.1</italic> was amplified using the forward primer 5’-GCT<underline>CCCGGG</underline>ATGGTACTTGAAGTCCCTCA-3’ and the reverse primer 5’-AGG<underline>TCTAGA</underline>ATCGGCAGCTGGCAATCCAC-3’. Because the nucleotide sequence of the <italic>npl-4.1</italic> gene is 99% identical to that of the <italic>npl-4.2</italic> gene, the cloned cDNA will target both of these genes. Therefore, the clone is referred to as <italic>npl-4</italic>. The fragment was cloned into the SmaI and XbaI sites of pL4440 (Open Biosystems) and transformed into <italic>E. coli</italic> HT115(DE3) cells.</p>
</sec>
<sec id="s4d">
<title>Plasmid constructs and generation of transgenic <italic>C. elegans</italic></title>
<p>For overexpression of <italic>elt-2</italic>, the <italic>elt-2</italic> gene along with its promoter region (1980-bp upstream) was amplified from genomic DNA of N2 animals. The gene, including its stop codon, was cloned in the pPD95.77 plasmid using the restriction sites PstI and SmaI. N2 worms were microinjected with <italic>elt-2p::elt-2</italic> plasmid along with pCFJ90 (<italic>myo-2p::mCherry</italic>) as a coinjection marker to generate the overexpression strain, <italic>jsnEx3 [elt-2p::elt-2 + myo-2p::mCherry]</italic>. The <italic>elt-2p::elt-2</italic> plasmid was used at a concentration of 50 ng/µl, while the coinjection marker was used at a concentration of 5 ng/µl.</p>
</sec>
<sec id="s4e">
<title>RNA interference (RNAi)</title>
<p>RNAi was used to generate loss-of-function phenotypes by feeding worms with <italic>E. coli</italic> strain HT115(DE3) expressing double-stranded RNA homologous to a target <italic>C. elegans</italic> gene.</p>
<p>RNAi was carried out as described previously (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>). Briefly, <italic>E. coli</italic> HT115(DE3) with the appropriate vectors were grown in LB broth containing ampicillin (100 μg/mL) at 37°C overnight on a shaker, concentrated ten times, and plated onto RNAi NGM plates containing 100 μg/mL ampicillin and 3 mM isopropyl β-D-thiogalactoside (IPTG). The plated bacteria were allowed to grow overnight at 37°C. For synchronization of worms, gravid adults were transferred to RNAi-expressing bacterial lawns and allowed to lay eggs for 2 hours. The gravid adults were removed, and the eggs were incubated at 20°C for 96 hours. For protease and IPR genes’ co-RNAi with <italic>ufd-1</italic>, <italic>E. coli</italic> HT115(DE3) with the appropriate vectors were grown separately at 37°C overnight until growth saturation. Then, the RNAi cultures were mixed in a ratio of 1:1, concentrated ten times, and plated onto RNAi plates, followed by overnight growth at 37°C. We used all the protease and <italic>pals</italic> genes that were upregulated upon <italic>ufd-1</italic> RNAi and were present in the Ahringer RNAi library. For experiments involving <italic>elt-2</italic> RNAi, the worms were grown on the control <italic>gfp</italic> RNAi (GFP) and <italic>ufd-1</italic> RNAi for 48 hours at 20°C to obtain the L4 stage worms. Afterward, the worms grown on <italic>gfp</italic> RNAi were transferred to GFP+<italic>elt-2</italic> RNAi plates, and those grown on <italic>ufd-1</italic> RNAi were transferred to GFP+<italic>ufd-1</italic> and <italic>ufd-1</italic>+<italic>elt-2</italic> RNAi plates. This was followed by the incubation of the worms at 20°C for another 48 hours before transferring to <italic>P. aeruginosa</italic> plates. The <italic>gfp</italic> RNAi <italic>E. coli</italic> HT115(DE3) strain was a kind gift from Scott G. Kennedy, Harvard Medical School.</p>
</sec>
<sec id="s4f">
<title>C. elegans killing assay on P. aeruginosa PA14</title>
<p>The full-lawn killing assays of <italic>C. elegans</italic> on <italic>P. aeruginosa</italic> PA14 were carried out as described earlier (<xref ref-type="bibr" rid="c51">Singh and Aballay, 2019a</xref>). Briefly, <italic>P. aeruginosa</italic> PA14 cultures were grown by inoculating individual bacterial colonies into 2 mL of LB broth and growing them for 8-10 hours on a shaker at 37°C. Then, 20 µL of the culture was spread on the complete surface of 3.5-cm-diameter standard slow-killing (SK) plates (modified NGM agar plates (0.35% instead of 0.25% peptone)). The plates were incubated at 37°C for 12-16 hours and then cooled to room temperature for at least 30 minutes before seeding with synchronized gravid adult hermaphrodite worms. The killing assays were performed at 25°C, and live animals were transferred to fresh plates every 24 hours. Animals were scored at the indicated times and considered dead when they failed to respond to touch. At least three independent experiments were performed for each condition.</p>
</sec>
<sec id="s4g">
<title><italic>P. aeruginosa</italic>-GFP colonization assay</title>
<p>The <italic>P. aeruginosa</italic> PA14-GFP colonization assays were carried out as described earlier (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>; <xref ref-type="bibr" rid="c52">Singh and Aballay, 2019b</xref>). Briefly, bacterial cultures were prepared by inoculating individual bacterial colonies into 2 mL of LB broth containing 50 μg/mL kanamycin and growing them for 8-10 hours on a shaker at 37°C. Then, 20 μL of the culture was spread on the complete surface of 3.5-cm-diameter SK plates containing 50 μg/mL kanamycin. The plates were incubated at 37°C for 12-16 hours and then cooled to room temperature for at least 30 min before seeding with gravid adult hermaphrodite worms. The assays were performed at 25°C. At indicated times, the worms were picked under a non-fluorescence stereomicroscope and visualized within 5 minutes under a fluorescence microscope.</p>
</sec>
<sec id="s4h">
<title>Quantification of intestinal bacterial loads</title>
<p>The quantification of intestinal <italic>P. aeruginosa</italic> PA14-GFP load was carried by measuring colony-forming units (CFU) as described earlier (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>). Briefly, <italic>P. aeruginosa</italic> PA14-GFP lawns were prepared as described above. At the indicated times for each experiment, the animals were transferred from <italic>P. aeruginosa</italic>-GFP plates to the center of fresh <italic>E. coli</italic> OP50 plates thrice for 10 minutes each to eliminate bacteria stuck to their body. Afterward, ten animals/condition were transferred into 50 μL of PBS containing 0.01% triton X-100 and ground using glass beads. Serial dilutions of the lysates (10<sup>1</sup>, 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup>) were seeded onto LB plates containing 50 μg/mL of kanamycin to select for <italic>P. aeruginosa</italic>-GFP cells and grown overnight at 37°C. Single colonies were counted the next day and represented as the number of bacterial cells or CFU per animal. Six independent experiments were performed for each condition.</p>
</sec>
<sec id="s4i">
<title>Pharyngeal Pumping Assay</title>
<p>For the pharyngeal pumping assay without <italic>P. aeruginosa</italic> PA14 exposure, wild-type N2 animals were grown on appropriate RNAi clones till 1-day-old adults before the measurements. For the pharyngeal pumping assay with <italic>P. aeruginosa</italic> PA14 exposure, wild-type N2 animals were grown on appropriate RNAi clones till 1-day-old adults, followed by exposure to <italic>P. aeruginosa</italic> PA14 for 12 hours at 25°C before measurements. The number of contractions of the terminal bulb of the pharynx was counted for 30 seconds per worm. The pumping rates for at least 30 worms were recorded for each condition.</p>
</sec>
<sec id="s4j">
<title>Measurement of defecation motor program (DMP) rate</title>
<p>The wild-type N2 animals were synchronized and grown at 20°C on EV, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi clones till 1-day-old adults before the measurements. For the DMP assay involving exposure of <italic>C. elegans</italic> to <italic>P. aeruginosa</italic> PA14, wild-type N2 animals were synchronized and grown at 20°C on EV, <italic>ufd-1</italic>, and <italic>npl-4</italic> RNAi clones till 1-day-old adults, followed by exposure to <italic>P. aeruginosa</italic> PA14 for 12 hours at 25°C before measurements. The DMP cycle length was scored by assessing the time between expulsions (which are preceded by posterior and anterior body wall muscle contraction and the contraction of enteric muscles in a normal, regular pattern) (<xref ref-type="bibr" rid="c57">Thomas, 1990</xref>). The number of expulsion events in 15 minutes was measured for each worm. The DMP rate was recorded for 9-13worms/condition.</p>
</sec>
<sec id="s4k">
<title><italic>C. elegans</italic> lifespan assays</title>
<p>Lifespan assays were performed as described earlier (<xref ref-type="bibr" rid="c9">Das et al., 2023</xref>). Briefly, the assays were performed on RNAi plates containing <italic>E. coli</italic> HT115(DE3) with appropriate vectors in the presence of 50 µg/mL of 5-fluorodeoxyuridine (FUdR). Animals were synchronized on RNAi plates without FUdR and incubated at 20°C. At the late L4 larval stage, the animals were transferred onto the corresponding RNAi plates containing 50 µg/mL of FUdR and incubated at 20°C. Animals were scored every day as live, dead, or gone. Animals that failed to display touch-provoked movement were scored as dead. Animals that crawled off the plates were censored. Experimental groups contained more than 60 animals per condition per replicate. Young adult animals were considered day 0 for the lifespan analysis. Three independent experiments were performed.</p>
</sec>
<sec id="s4l">
<title>RNA isolation, RNA sequencing, and data analysis</title>
<p>RNA isolation was carried out as described earlier (<xref ref-type="bibr" rid="c53">Singh and Aballay, 2017</xref>). Briefly, animals were synchronized by egg laying. Approximately 35 N2 gravid adult animals were transferred to 10-cm RNAi plates seeded with control empty vector and <italic>ufd-1</italic> RNAi bacteria and allowed to lay eggs for 4 hours. The gravid adults were then removed, and the eggs were allowed to develop at 20°C for 96 hours. The animals were then collected, washed with M9 buffer, and frozen in TRIzol reagent (Life Technologies, Carlsbad, CA). Total RNA was extracted using the RNeasy Plus Universal Kit (Qiagen, Netherlands). Residual genomic DNA was removed using TURBO DNase (Life Technologies, Carlsbad, CA). Library preparation and sequencing were performed at the Novogene Corporation Inc, USA. The cDNA libraries were sequenced on the HiSeqX sequencing platform using 150 bp paired-end nucleotide reads.</p>
<p>The RNA sequence data were analyzed using the web platform Galaxy (<ext-link ext-link-type="uri" xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</ext-link>). The paired reads were first trimmed using the Trimmomatic tool. The trimmed reads obtained for each sample were mapped to the <italic>C. elegans</italic> genome (WS220) using the aligner STAR. The number of reads mapped to each gene was counted using the <italic>htseq-count</italic> tool. Differential gene expression analysis was then performed using DESeq2. Genes exhibiting at least a two-fold change and <italic>P</italic>-value &lt;0.01 were considered differentially expressed. Gene ontology analysis was performed using the DAVID Bioinformatics Database (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/tools.jsp">https://david.ncifcrf.gov/tools.jsp</ext-link>). The overlap of the upregulated genes with previously published datasets was carried out with WormExp v 2.0 (<ext-link ext-link-type="uri" xlink:href="https://wormexp.zoologie.uni-kiel.de/wormexp/">https://wormexp.zoologie.uni-kiel.de/wormexp/</ext-link>) (<xref ref-type="bibr" rid="c65">Yang et al., 2016b</xref>). The Venn diagrams were obtained using the web tool BioVenn (<ext-link ext-link-type="uri" xlink:href="https://www.biovenn.nl/">https://www.biovenn.nl/</ext-link>) (<xref ref-type="bibr" rid="c21">Hulsen et al., 2008</xref>).</p>
</sec>
<sec id="s4m">
<title>RNA isolation and quantitative reverse transcription-PCR (qRT-PCR)</title>
<p>Animals were synchronized by egg laying. Approximately 40 N2 gravid adults were transferred to 9-cm RNAi plates seeded with <italic>E. coli</italic> HT115 expressing the appropriate vectors and allowed to lay eggs for 4 hours. The adults were then removed, and the eggs were allowed to develop at 20°C for 96 hours. The resulting animals were collected, washed with M9 buffer three times, and frozen in TRIzol reagent (Life Technologies, Carlsbad, CA). Total RNA was extracted using the RNeasy Plus Universal Kit (Qiagen, Netherlands). qRT-PCR was carried out as described earlier (<xref ref-type="bibr" rid="c15">Ghosh and Singh, 2024</xref>). Briefly, total RNA was reverse-transcribed with random primers using the PrimeScript™ 1st strand cDNA Synthesis Kit (TaKaRa) according to the manufacturer’s protocols. qRT-PCR was conducted using TB Green fluorescence (TaKaRa) on a MasterCycler EP Realplex 4 thermal cycler (Eppendorf) in 96-well-plate format. Fifteen microliter reactions were analyzed as outlined by the manufacturer (TaKaRa). Relative fold changes of the transcripts were calculated using the comparative <italic>CT</italic> (2<sup>-ΔΔ<italic>CT</italic></sup>) method and normalized to pan-actin (<italic>act-1,-3,-4</italic>) as previously described (<xref ref-type="bibr" rid="c53">Singh and Aballay, 2017</xref>). All samples were run in triplicate (technical replicates) and repeated at least four times (biological replicates).</p>
</sec>
<sec id="s4n">
<title>Fluorescence imaging</title>
<p>Fluorescence imaging was carried out as described previously (<xref ref-type="bibr" rid="c16">Gokul and Singh, 2022</xref>; <xref ref-type="bibr" rid="c41">Ravi et al., 2023</xref>). Briefly, the animals were anesthetized using an M9 salt solution containing 50 mM sodium azide and mounted onto 2% agarose pads. The animals were then visualized using a Nikon SMZ-1000 fluorescence stereomicroscope. The fluorescence intensity was quantified using Image J software.</p>
</sec>
<sec id="s4o">
<title>Quantification and statistical analysis</title>
<p>The statistical analysis was performed with Prism 8 (GraphPad). All error bars represent mean±standard deviation (SD). The two-sample <italic>t</italic>-test was used when needed, and the data were judged to be statistically significant when <italic>P</italic> &lt; 0.05. In the figures, asterisks (*) denote statistical significance as follows: *, <italic>P</italic> &lt; 0.05, **, <italic>P</italic> &lt; 0.01, ***, <italic>P</italic> &lt; 0.001, as compared with the appropriate controls. The Kaplan-Meier method was used to calculate the survival fractions, and statistical significance between survival curves was determined using the log-rank test. All experiments were performed in triplicate.</p>
</sec>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability">
<title>Data availability</title>
<p>The RNA sequencing data for N2 worms grown on empty vector control and <italic>ufd-1</italic> RNAi have been submitted to the public repository, the Sequence Read Archive, with BioProject ID PRJNA1033335. All data generated or analyzed during this study are included in the manuscript and supporting files.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>Some strains used in this study were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).</p>
</ack>
<sec id="d1e2396" sec-type="additional-information">
<title>Additional information</title>
<sec id="s5">
<title>Funding</title>
<p>This work was supported by the following grants: Ramalingaswami Re-entry Fellowship (Ref. No. BT/RLF/Re-entry/50/2020) and Har-Gobind Khorana-Innovative Young Biotechnologist Fellowship (File No. HRD-17011/2/2023-HRD-DBT) awarded by the Department of Biotechnology, India; STARS grant (File No. MoE-STARS/STARS-2/2023-0116) awarded by the Ministry of Education, India; Research Grant (Ref. No. 37/1741/23/EMR-II) awarded by the Council of Scientific &amp; Industrial Research (CSIR), India; Science and Engineering Research Board (SERB) Startup (Ref. No. SRG/2020/000022) and Core (Ref. No. CRG/2023/001136) Research Grants awarded by DST, India; and IISER Mohali intramural funds. RR was supported by a senior research fellowship from the CSIR, India.</p>
</sec>
</sec>
<sec id="suppd1e2396" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="tbls1">
<label>Table S1.</label>
<caption><title>Upregulated and downregulated genes in <italic>ufd-1</italic> RNAi versus empty vector (EV) control RNAi N2 animals.</title>
<p>Genes exhibiting at least a two-fold change and <italic>P</italic>-value &lt;0.01 were considered differentially expressed.</p></caption>
<media xlink:href="supplements/571255_file03.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amrit</surname> <given-names>FRG</given-names></string-name>, <string-name><surname>Naim</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ratnappan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Loose</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mason</surname> <given-names>C</given-names></string-name>, <string-name><surname>Steenberge</surname> <given-names>L</given-names></string-name>, <string-name><surname>McClendon</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Driscoll</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yanowitz</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Ghazi</surname> <given-names>A</given-names></string-name></person-group>. <year>2019</year>. <article-title>The longevity-promoting factor, TCER-1, widely represses stress resistance and innate immunity</article-title>. <source>Nat Commun</source> <volume>10</volume>:<fpage>3042</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-019-10759-z</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bakowski</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Desjardins</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Smelkinson</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Dunbar</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Lopez-Moyado</surname> <given-names>IF</given-names></string-name>, <string-name><surname>Rifkin</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Cuomo</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Troemel</surname> <given-names>ER</given-names></string-name></person-group>. <year>2014</year>. <article-title>Ubiquitin-Mediated Response to Microsporidia and Virus Infection in C. elegans</article-title>. <source>PLoS Pathog</source> <volume>10</volume>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004200</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bodnar</surname> <given-names>NO</given-names></string-name>, <string-name><surname>Rapoport</surname> <given-names>TA</given-names></string-name></person-group>. <year>2017</year>. <article-title>Molecular Mechanism of Substrate Processing by the Cdc48 ATPase Complex</article-title>. <source>Cell</source> <volume>169</volume>:<fpage>722</fpage>–<lpage>735</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2017.04.020</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bomberger</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Ye</surname> <given-names>S</given-names></string-name>, <string-name><surname>Maceachran</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Koeppen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Barnaby</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Toole</surname> <given-names>GAO</given-names></string-name>, <string-name><surname>Stanton</surname> <given-names>BA</given-names></string-name></person-group>. <year>2011</year>. <article-title>A Pseudomonas aeruginosa Toxin that Hijacks the Host Ubiquitin Proteolytic System</article-title>. <source>PLoS Pathog</source> <volume>7</volume>:<fpage>e1001325</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1001325</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Boom J</given-names> <surname>Van Den</surname></string-name>, <string-name><surname>Meyer</surname> <given-names>H.</given-names></string-name></person-group> <year>2018</year>. <article-title>VCP/p97-Mediated Unfolding as a Principle in Protein Homeostasis and Signaling</article-title>. <source>Mol Cell</source> <volume>69</volume>:<fpage>182</fpage>–<lpage>194</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2017.10.028</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chai</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Qiang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ge</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zhong</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Li</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>D</given-names></string-name>, <string-name><surname>Li</surname> <given-names>W</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>W</given-names></string-name>, <string-name><surname>Pang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>GF</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>CH</given-names></string-name></person-group>. <year>2019</year>. <article-title>A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy</article-title>. <source>Nat Commun</source> <volume>10</volume>:<fpage>1973</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-019-09955-8</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheesman</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Feinbaum</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Thekkiniath</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dowen</surname> <given-names>RH</given-names></string-name>, <string-name><surname>Conery</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Pukkila-Worley</surname> <given-names>R</given-names></string-name></person-group>. <year>2016</year>. <article-title>Aberrant Activation of p38 MAP Kinase-Dependent Innate Immune Responses Is Toxic to Caenorhabditis elegans</article-title>. <source>G3 (Bethesda)</source> <volume>6</volume>:<fpage>541</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1534/g3.115.025650</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clague</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Urbe</surname> <given-names>S</given-names></string-name></person-group>. <year>2010</year>. <article-title>Ubiquitin: Same Molecule, Different Degradation Pathways</article-title>. <source>Cell</source> <volume>143</volume>:<fpage>682</fpage>–<lpage>685</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2010.11.012</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Das</surname> <given-names>P</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>J</given-names></string-name></person-group>. <year>2023</year>. <article-title>Calcineurin inhibition enhances Caenorhabditis elegans lifespan by defecation defects-mediated calorie restriction and nuclear hormone signaling</article-title>. <source>eLife</source> <volume>12</volume>:<elocation-id>RP89572</elocation-id>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dikic</surname> <given-names>I</given-names></string-name></person-group>. <year>2017</year>. <article-title>Proteasomal and Autophagic Degradation Systems</article-title>. <source>Annu Rev Biochem</source> <volume>86</volume>:<fpage>193</fpage>–<lpage>224</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dineen</surname> <given-names>A</given-names></string-name>, <string-name><surname>Osborne</surname> <given-names>E</given-names></string-name>, <string-name><surname>Goszczynski</surname> <given-names>B</given-names></string-name>, <string-name><surname>Rothman</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Mcghee</surname> <given-names>JD</given-names></string-name></person-group>. <year>2018</year>. <article-title>Quantitating transcription factor redundancy: The relative roles of the ELT-2 and ELT-7 GATA factors in the C. elegans endoderm</article-title>. <source>Dev Biol</source> <volume>435</volume>:<fpage>150</fpage>–<lpage>161</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ydbio.2017.12.023</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ding</surname> <given-names>W-X</given-names></string-name>, <string-name><surname>Yin</surname> <given-names>X-M</given-names></string-name></person-group>. <year>2008</year>. <article-title>Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome</article-title>. <source>Autophagy</source> <volume>4</volume>:<fpage>141</fpage>–<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.4161/auto.5190</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Engel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Barton</surname> <given-names>GM</given-names></string-name></person-group>. <year>2010</year>. <article-title>Unfolding new roles for XBP1 in immunity</article-title>. <source>Nat Immunol</source> <volume>11</volume>:<fpage>365</fpage>–<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni0510-365</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garcia-Sanchez</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Ewbank</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Visvikis</surname> <given-names>O</given-names></string-name></person-group>. <year>2021</year>. <article-title>Ubiquitin-related processes and innate immunity in C. elegans</article-title>. <source>Cellular and Molecular Life Sciences</source> <volume>78</volume>:<fpage>4305</fpage>–<lpage>4333</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00018-021-03787-w</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ghosh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>J</given-names></string-name></person-group>. <year>2024</year>. <article-title>Translation initiation or elongation inhibition triggers contrasting effects on Caenorhabditis elegans survival during pathogen infection</article-title>. <source>mBio</source> <volume>15</volume>:<fpage>e0248524</fpage>. doi:<pub-id pub-id-type="doi">10.1128/mbio.02485-24</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gokul</surname> <given-names>G</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>Dithiothreitol causes toxicity in C. elegans by modulating the methionine-homocysteine cycle</article-title>. <source>eLife</source> <volume>11</volume>:<elocation-id>e76021</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.76021</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haldar</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Foltz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Finethy</surname> <given-names>R</given-names></string-name>, <string-name><surname>Piro</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Feeley</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Pilla-moffett</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Komatsuc</surname> <given-names>M</given-names></string-name>, <string-name><surname>Frickelb</surname> <given-names>E-M</given-names></string-name>, <string-name><surname>Coers</surname> <given-names>J</given-names></string-name></person-group>. <year>2015</year>. <article-title>Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>112</volume>:<fpage>E5628</fpage>–<lpage>E5637</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1515966112</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Head</surname> <given-names>B</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2014</year>. <article-title>Recovery from an Acute Infection in C. elegans Requires the GATA Transcription Factor ELT-2</article-title>. <source>PLoS Genet</source> <volume>10</volume>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1004609</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herhaus</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dikic</surname> <given-names>I</given-names></string-name></person-group>. <year>2018</year>. <article-title>Regulation of Salmonella-host cell interactions via the ubiquitin system</article-title>. <source>International Journal of Medical Microbiology</source> <volume>308</volume>:<fpage>176</fpage>–<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijmm.2017.11.003</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hetz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chevet</surname> <given-names>E</given-names></string-name>, <string-name><surname>Oakes</surname> <given-names>SA</given-names></string-name></person-group>. <year>2015</year>. <article-title>Proteostasis control by the unfolded protein response</article-title>. <source>Nat Cell Biol</source> <volume>17</volume>:<fpage>829</fpage>–<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb3184</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hulsen</surname> <given-names>T</given-names></string-name>, <string-name><surname>de Vlieg</surname> <given-names>J</given-names></string-name>, <string-name><surname>Alkema</surname> <given-names>W.</given-names></string-name></person-group> <year>2008</year>. <article-title>BioVenn - A web application for the comparison and visualization of biological lists using area-proportional Venn diagrams</article-title>. <source>BMC Genomics</source> <volume>9</volume>:<fpage>488</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2164-9-488</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Husnjak</surname> <given-names>K</given-names></string-name>, <string-name><surname>Dikic</surname> <given-names>I</given-names></string-name></person-group>. <year>2012</year>. <article-title>Ubiquitin-Binding Proteins: Decoders of Ubiquitin-Mediated Cellular Functions</article-title>. <source>Annu Rev Biochem</source> <volume>81</volume>:<fpage>291</fpage>–<lpage>322</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-biochem-051810-094654</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Feinbaum</surname> <given-names>R</given-names></string-name>, <string-name><surname>Alloing</surname> <given-names>G</given-names></string-name>, <string-name><surname>Emerson</surname> <given-names>FE</given-names></string-name>, <string-name><surname>Garsin</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Inoue</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tanaka-Hino</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hisamoto</surname> <given-names>N</given-names></string-name>, <string-name><surname>Matsumoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>M-W</given-names></string-name>, <string-name><surname>Ausubel</surname> <given-names>FM.</given-names></string-name></person-group> <year>2002</year>. <article-title>A Conserved p38 MAP Kinase Pathway in Caenorhabditis elegans Innate Immunity</article-title>. <source>Science (1979)</source> <volume>297</volume>:<fpage>623</fpage>–<lpage>626</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1073759</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Thakur</surname> <given-names>N</given-names></string-name>, <string-name><surname>Piggott</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Omi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Polanowska</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Pujol</surname> <given-names>N</given-names></string-name></person-group>. <year>2016</year>. <article-title>Coordinated inhibition of C/EBP by Tribbles in multiple tissues is essential for Caenorhabditis elegans development</article-title>. <source>BMC Biol</source> <volume>14</volume>:<fpage>104</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12915-016-0320-z</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lažetić</surname> <given-names>V</given-names></string-name>, <string-name><surname>Blanchard</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Bui</surname> <given-names>T</given-names></string-name>, <string-name><surname>Troemel</surname> <given-names>ER</given-names></string-name></person-group>. <year>2023</year>. <article-title>Multiple pals gene modules control a balance between immunity and development in Caenorhabditis elegans</article-title>. <source>PLoS Pathog</source> <volume>19</volume>:<fpage>e1011120</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1011120</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lim</surname> <given-names>T</given-names></string-name>, <string-name><surname>Eng</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ijap</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Lau</surname> <given-names>M-S</given-names></string-name>, <string-name><surname>Lim</surname> <given-names>M-P</given-names></string-name>, <string-name><surname>Gan</surname> <given-names>Y-H</given-names></string-name>, <string-name><surname>He</surname> <given-names>F-L</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>M-W</given-names></string-name>, <string-name><surname>Nathan</surname> <given-names>S</given-names></string-name></person-group>. <year>2013</year>. <article-title>Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>110</volume>:<fpage>15067</fpage>–<lpage>15072</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1311725110</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chai</surname> <given-names>Q-Y</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>CH</given-names></string-name></person-group>. <year>2016</year>. <article-title>The ubiquitin system: a critical regulator of innate immunity and pathogen–host interactions</article-title>. <source>Cell Mol Immunol</source> <volume>13</volume>:<fpage>560</fpage>–<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.1038/cmi.2016.40</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liberati</surname> <given-names>NT</given-names></string-name>, <string-name><surname>Fitzgerald</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Feinbaum</surname> <given-names>R</given-names></string-name>, <string-name><surname>Golenbock</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Ausubel</surname> <given-names>FM</given-names></string-name></person-group>. <year>2004</year>. <article-title>Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>101</volume>:<fpage>6593</fpage>–<lpage>6598</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0308625101</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mallo</surname> <given-names>GV</given-names></string-name>, <string-name><surname>Le</surname> <given-names>C</given-names></string-name>, <string-name><surname>Couillault</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pujol</surname> <given-names>N</given-names></string-name>, <string-name><surname>Granjeaud</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kohara</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ewbank</surname> <given-names>JJ.</given-names></string-name></person-group> <year>2002</year>. <article-title>Inducible Antibacterial Defense System in C. elegans</article-title>. <source>Current Biology</source> <volume>12</volume>:<fpage>1209</fpage>–<lpage>1214</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mann</surname> <given-names>FG</given-names></string-name>, <string-name><surname>Nostrand</surname> <given-names>EL Van</given-names></string-name>, <string-name><surname>Friedland</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>SK</given-names></string-name></person-group>. <year>2016</year>. <article-title>Deactivation of the GATA Transcription Factor ELT-2 Is a Major Driver of Normal Aging in C. elegans</article-title>. <source>PLoS Genet</source> <volume>12</volume>:<fpage>e1005956</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1005956</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tian</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Jung</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ferreira</surname> <given-names>RB</given-names></string-name>, <string-name><surname>Carroll</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Blackwell</surname> <given-names>TK</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>J</given-names></string-name></person-group>. <year>2021</year>. <article-title>Global profiling of distinct cysteine redox forms reveals wide-ranging redox regulation in C. elegans</article-title>. <source>Nat Commun</source> <volume>12</volume>:<fpage>1415</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-021-21686-3</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bug</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bremer</surname> <given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Emerging functions of the VCP / p97 AAA-ATPase in the ubiquitin system</article-title>. <source>Nat Cell Biol</source> <volume>14</volume>:<fpage>117</fpage>–<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncb2407</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Shorter</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Seemann</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pappin</surname> <given-names>D</given-names></string-name>, <string-name><surname>Warren</surname> <given-names>G</given-names></string-name></person-group>. <year>2000</year>. <article-title>A complex of mammalian Ufd1 and Npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways</article-title>. <source>EMBO J</source> <volume>19</volume>:<fpage>2181</fpage>–<lpage>2192</lpage>. doi:<pub-id pub-id-type="doi">10.1093/emboj/19.10.2181</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mouysset</surname> <given-names>J</given-names></string-name>, <string-name><surname>Deichsel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Moser</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hoege</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hyman</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Gartner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hoppe</surname> <given-names>T</given-names></string-name></person-group>. <year>2008</year>. <article-title>Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>:<fpage>12879</fpage>–<lpage>12884</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0805944105</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mouysset</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kähler</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hoppe</surname> <given-names>T</given-names></string-name></person-group>. <year>2006</year>. <article-title>A conserved role of Caenorhabditis elegans CDC-48 in ER-associated protein degradation</article-title>. <source>J Struct Biol</source> <volume>156</volume>:<fpage>41</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsb.2006.02.015</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mukhopadhyay</surname> <given-names>D</given-names></string-name>, <string-name><surname>Riezman</surname> <given-names>H</given-names></string-name></person-group>. <year>2007</year>. <article-title>Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling</article-title>. <source>Science (1979)</source> <volume>315</volume>:<fpage>201</fpage>–<lpage>205</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olaitan</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2018</year>. <article-title>Non-proteolytic activity of 19S proteasome subunit RPT-6 regulates GATA transcription during response to infection</article-title>. <source>PLoS Genet</source> <volume>14</volume>:<fpage>e1007693</fpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Otarigho</surname> <given-names>B</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2021</year>. <article-title>Immunity-longevity tradeoff neurally controlled by GABAergic transcription factor PITX1/UNC-30</article-title>. <source>Cell Rep</source> <volume>35</volume>:<fpage>109187</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2021.109187</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Otten</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Werner</surname> <given-names>E</given-names></string-name>, <string-name><surname>Crespillo-casado</surname> <given-names>A</given-names></string-name>, <string-name><surname>Boyle</surname> <given-names>KB</given-names></string-name>, <string-name><surname>Dharamdasani</surname> <given-names>V</given-names></string-name>, <string-name><surname>Pathe</surname> <given-names>C</given-names></string-name>, <string-name><surname>Santhanam</surname> <given-names>B</given-names></string-name>, <string-name><surname>Randow</surname> <given-names>F</given-names></string-name></person-group>. <year>2021</year>. <article-title>Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection</article-title>. <source>Nature</source> <volume>594</volume>:<fpage>111</fpage>–<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-021-03566-4</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peterson</surname> <given-names>ND</given-names></string-name>, <string-name><surname>Icso</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Salisbury</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Rodríguez</surname> <given-names>T</given-names></string-name>, <string-name><surname>Thompson</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Pukkila-Worley</surname> <given-names>R</given-names></string-name></person-group>. <year>2022</year>. <article-title>Pathogen infection and cholesterol deficiency activate the C. elegans p38 immune pathway through a TIR-1/SARM1 phase transition</article-title>. <source>eLife</source> <volume>11</volume>:<elocation-id>e74206</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.74206</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ravi</surname>, <given-names>Kumar A</given-names></string-name>, <string-name><surname>Bhattacharyya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>J</given-names></string-name></person-group>. <year>2023</year>. <article-title>Thiol reductive stress activates the hypoxia response pathway</article-title>. <source>EMBO J</source> <volume>42</volume>:<fpage>e114093</fpage>. doi:<pub-id pub-id-type="doi">10.15252/embj.2023114093</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reddy</surname> <given-names>KC</given-names></string-name>, <string-name><surname>Dror</surname> <given-names>T</given-names></string-name>, <string-name><surname>Underwood</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Osman</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Elder</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Desjardins</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Cuomo</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Barkoulas</surname> <given-names>M</given-names></string-name>, <string-name><surname>Troemel</surname> <given-names>ER</given-names></string-name></person-group>. <year>2019</year>. <article-title>Antagonistic paralogs control a switch between growth and pathogen resistance in C. elegans</article-title>. <source>PLoS Pathog</source> <volume>15</volume>:<fpage>e1007528</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1007528</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ren</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Ambros</surname> <given-names>VR</given-names></string-name></person-group>. <year>2015</year>. <article-title>Caenorhabditis elegans microRNAs of the let-7 family act in innate immune response circuits and confer robust developmental timing against pathogen stress</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>112</volume>:<fpage>E2366</fpage>–<lpage>E2375</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1422858112</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ribet</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cossart</surname> <given-names>P</given-names></string-name></person-group>. <year>2018</year>. <article-title>Ubiquitin, SUMO, and NEDD8: Key Targets of Bacterial Pathogens</article-title>. <source>Trends Cell Biol</source> <volume>28</volume>:<fpage>926</fpage>–<lpage>940</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2018.07.005</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richardson</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Kooistra</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>DH</given-names></string-name></person-group>. <year>2010</year>. <article-title>An essential role for XBP-1 in host protection against immune activation in C. elegans</article-title>. <source>Nature</source> <volume>463</volume>:<fpage>1092</fpage>–<lpage>1095</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature08762</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sarkies</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ashe</surname> <given-names>A</given-names></string-name>, <string-name><given-names>Pen J</given-names> <surname>Le</surname></string-name>, <string-name><surname>Mckie</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Miska</surname> <given-names>EA</given-names></string-name></person-group>. <year>2013</year>. <article-title>Competition between virus-derived and endogenous small RNAs regulates gene expression in Caenorhabditis elegans</article-title>. <source>Genome Res</source> <volume>23</volume>:<fpage>1258</fpage>–<lpage>1270</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.153296.112</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sasagawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yamanaka</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ogura</surname> <given-names>T</given-names></string-name></person-group>. <year>2007</year>. <article-title>ER E3 ubiquitin ligase HRD-1 and its specific partner chaperone BiP play important roles in ERAD and developmental growth in Caenorhabditis elegans</article-title>. <source>Genes to Cells</source> <volume>12</volume>:<fpage>1063</fpage>–<lpage>1073</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2443.2007.01108.x</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shapira</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hamlin</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Rong</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ronen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>M-W</given-names></string-name></person-group>. <year>2006</year>. <article-title>A conserved role for a GATA transcription factor in regulating epithelial innate immune responses</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>103</volume>:<fpage>14086</fpage>–<lpage>91</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0603424103</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>J</given-names></string-name></person-group>. <year>2023</year>. <article-title>ERASing endoplasmic reticulum stress: the faster, the better</article-title>. <source>Trends Cell Biol</source> <volume>33</volume>:<fpage>179</fpage>–<lpage>181</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2022.12.003</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>J</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2020</year>. <article-title>Neural control of behavioral and molecular defenses in C. elegans</article-title>. <source>Curr Opin Neurobiol</source> <volume>62</volume>:<fpage>34</fpage>–<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.conb.2019.10.012</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>J</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2019a</year>. <article-title>Intestinal infection regulates behavior and learning via neuroendocrine signaling</article-title>. <source>eLife</source> <volume>8</volume>:<elocation-id>e50033</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.50033</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>J</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2019b</year>. <article-title>Microbial colonization activates an immune fight-and-flight response via neuroendocrine signaling</article-title>. <source>Dev Cell</source> <volume>49</volume>:<fpage>89</fpage>–<lpage>99</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.devcel.2019.02.001</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>J</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2017</year>. <article-title>Endoplasmic reticulum stress caused by lipoprotein accumulation suppresses immunity against bacterial pathogens and contributes to immunosenescence</article-title>. <source>mBio</source> <volume>8</volume>:<fpage>e00778</fpage>–<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00778-17</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Aballay</surname> <given-names>A</given-names></string-name></person-group>. <year>2012</year>. <article-title>Organismal regulation of XBP-1-mediated unfolded protein response during development and immune activation</article-title>. <source>EMBO Rep</source> <volume>13</volume>:<fpage>855</fpage>–<lpage>860</lpage>. doi:<pub-id pub-id-type="doi">10.1038/embor.2012.100</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Mahajan-Miklos</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ausubel</surname> <given-names>FM</given-names></string-name></person-group>. <year>1999</year>. <article-title>Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>96</volume>:<fpage>715</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.96.2.715</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taylor</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Dillin</surname> <given-names>A</given-names></string-name></person-group>. <year>2013</year>. <article-title>XBP-1 Is a cell-nonautonomous regulator of stress resistance and longevity</article-title>. <source>Cell</source> <volume>153</volume>:<fpage>1435</fpage>–<lpage>1447</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2013.05.042</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thomas</surname> <given-names>JH</given-names></string-name></person-group>. <year>1990</year>. <article-title>Genetic analysis of defecation in Caenorhabditis elegans</article-title>. <source>Genetics</source> <volume>124</volume>:<fpage>855</fpage>–<lpage>872</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0168-9525(90)90166-4</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tripathi-Giesgen</surname> <given-names>I</given-names></string-name>, <string-name><surname>Behrends</surname> <given-names>C</given-names></string-name>, <string-name><surname>Alpi</surname> <given-names>AF</given-names></string-name></person-group>. <year>2021</year>. <article-title>The ubiquitin ligation machinery in the defense against bacterial pathogens</article-title>. <source>EMBO Rep</source> <volume>22</volume>:<fpage>e52864</fpage>. doi:<pub-id pub-id-type="doi">10.15252/embr.202152864</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vembar</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Brodsky</surname> <given-names>JL</given-names></string-name></person-group>. <year>2008</year>. <article-title>One step at a time: endoplasmic reticulum-associated degradation</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>9</volume>:<fpage>944</fpage>–<lpage>957</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm2546</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vilchez</surname> <given-names>D</given-names></string-name>, <string-name><surname>Saez</surname> <given-names>I</given-names></string-name>, <string-name><surname>Dillin</surname> <given-names>A</given-names></string-name></person-group>. <year>2014</year>. <article-title>The role of protein clearance mechanisms in organismal ageing and age-related diseases</article-title>. <source>Nat Commun</source> <volume>5</volume>:<fpage>5659</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms6659</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Visvikis</surname> <given-names>O</given-names></string-name>, <string-name><surname>Ihuegbu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Labed</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Luhachack</surname> <given-names>LG</given-names></string-name>, <string-name><surname>Alves</surname> <given-names>AMF</given-names></string-name>, <string-name><surname>Wollenberg</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Stuart</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Stormo</surname> <given-names>GD</given-names></string-name>, <string-name><surname>Irazoqui</surname> <given-names>JE</given-names></string-name></person-group>. <year>2014</year>. <article-title>Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes</article-title>. <source>Immunity</source> <volume>40</volume>:<fpage>896</fpage>–<lpage>909</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2014.05.002</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Stolz</surname> <given-names>A</given-names></string-name></person-group>. <year>2012</year>. <article-title>The Cdc48 machine in endoplasmic reticulum associated protein degradation ⋆</article-title>. <source>Biochim Biophys Acta</source> <volume>1823</volume>:<fpage>117</fpage>–<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbamcr.2011.09.002</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Rapoport</surname> <given-names>TA</given-names></string-name></person-group>. <year>2018</year>. <article-title>Mechanistic insights into ER-associated protein degradation</article-title>. <source>Curr Opin Cell Biol</source> <volume>53</volume>:<fpage>22</fpage>–<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ceb.2018.04.004</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Dierking</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rosenstiel</surname> <given-names>PC</given-names></string-name>, <string-name><surname>Schulenburg</surname> <given-names>H</given-names></string-name></person-group>. <year>2016a</year>. <article-title>GATA transcription factor as a likely key regulator of the Caenorhabditis elegans innate immune response against gut pathogens</article-title>. <source>Zoology</source> <volume>119</volume>:<fpage>244</fpage>–<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.zool.2016.05.013</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Dierking</surname> <given-names>K</given-names></string-name>, <string-name><surname>Schulenburg</surname> <given-names>H</given-names></string-name></person-group>. <year>2016b</year>. <article-title>WormExp: A web-based application for a Caenorhabditis elegans-specific gene expression enrichment analysis</article-title>. <source>Bioinformatics</source> <volume>32</volume>:<fpage>943</fpage>–<lpage>945</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btv667</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Rapoport</surname> <given-names>TA</given-names></string-name></person-group>. <year>2001</year>. <article-title>The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol</article-title>. <source>Nature</source> <volume>414</volume>:<fpage>652</fpage>–<lpage>656</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94310.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vance</surname>
<given-names>Russell E</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of California, Berkeley</institution>
</institution-wrap>
<city>Berkeley</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>In this <bold>valuable</bold> manuscript, Rao and colleagues investigate the UFD-1/NPL-4 complex, which is involved in extracting misfolded proteins in the plasma membrane and the accumulation of pathogenic bacteria in the intestine. Using <bold>convincing</bold> methods, the authors find that knockdown of the ufd-1 and npl-4 genes leads to shortened lifespan of the nematode C. elegans and reduced accumulation of the bacterial pathogen P. aeruginosa in the intestine.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94310.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The authors adequately addressed the concerns I raised in my initial review, which are noted below.</p>
<p>(1) I suggest that the authors choose a different term in their title, abstract and manuscript to describe the phenotypes associated with ufd-1 and npl-4 knockdown other than an &quot;inflammation-like response.&quot; Inflammation is a pathological term with four cardinal signs: redness (rubor), swelling (tumor), warmth (calor) and pain (dolor). These are not symptoms known to occur in C. elegans. The authors could consider using &quot;inappropriate,&quot; &quot;aberrant&quot; or &quot;toxic&quot; immune activation in the title and abstract.</p>
<p>(2) I think it is important to point out in the context of the authors novelty claim in the abstract and manuscript that the toxic effects of inappropriate immune activation in C. elegans has been widely catalogued. For example: doi.org/10.1371/journal.ppat.1011120 (2023); doi:10.1186/s12915-016-0320-z (2016).; doi:10.1126/science.1203411 (2011); doi:10.1534/g3.115.025650 (2016). In addition, doi:10.7554/eLife.74206 (2022) previously described a mutation that caused innate immune activation that reduced accumulation of P. aeruginosa in the intestine, but also caused animals to have a shortened lifespan.</p>
<p>Thus, I do not think this study reveals the existence of inflammatory-like responses in C. elegans, as stated by the authors. Indeed, I think it is important for the authors to remove this novelty claim from their paper and discuss their work in the context of these studies in a paragraph in the introduction.</p>
<p>(3) The authors rely on the use of RNAi of ufd-1 and npl-4 to study their effect on P. aeruginosa colonization and pathogen resistance throughout the manuscript. To address the possibility of off-target effects of the RNAi, the authors should consider both (i) showing with qRT-PCR that these genes are indeed targeted during RNAi, and (ii) confirming their phenotypes with an orthologous technique, preferably by studying ufd-1 and npl-4 loss-of-function mutants [both in the wild-type and sek-1(km4) backgrounds]. If mutation of these genes is lethal, the authors could use Auxin Inducible Degron (AID) technology to induce the degradation of these proteins in post-developmental animals.</p>
<p>(4) I am confused about the author's explanation regarding their observation that inhibition of the UFD-1/ NPL-4 complex extends the lifespan of sek-1(km25) animals, but not pmk-1(km25) animals, as SEK-1 is the MAPKK that functions immediately upstream of the p38 MAPK PMK-1 to promote pathogen resistance.</p>
<p>I am also confused why their RNA-seq experiment revealed a signature of intracellular pathogen response genes and not PMK-1 targets, which the authors propose is accounting for toxic immune activation. Activation of which immune response leads to toxicity?</p>
<p>(5) The authors did not test alternative explanations for why UFD-1/ NPL-4 complex inhibition compromises survival during pathogen infection, other than exuberant immune activation. For example, it is possible that inhibition of this proteosome complex shortens lifespan by compromising the general health/ normal physiology of nematodes. Immune responses could be activated as a secondary consequence of this stress, and not be a direct cause of early mortality. Does sek-1(km4) mutant suppress the lifespan shortened lifespan of ufd-1 and npl-4 knockdown? This experiment should also be done with loss-of-function mutants, as noted in point 3.</p>
<p>(6) The conclusion of Figure 6 hinges on an experiment that uses double RNAi to knockdown two genes at the same time (Fig. 6D and 6G), an approach that is inherently fraught in C. elegans biology owing to the likelihood that the efficiency of RNAi-mediated gene knockdown is compromised and may account for the observed phenotypes. The proper control for double RNAi is not empty vector + ufd-1(RNAi), but rather gfp(RNAi) + ufd-1(RNAi), as the introduction of a second hairpin RNA is what may compromise knockdown efficiency. In this context, it is important to confirm that knockdown of both genes occurs as expected (with qRT-PCR) and to confirm this phenotype using available elt-2 loss-of-function mutants.</p>
<p>(7) A supplementary table with the source data for at least three replications (mean lifespan, n, statistical comparison) for each pathogenesis assay should be included in this manuscript.</p>
<p>Comments on revisions:</p>
<p>The authors adequately addressed the concerns I raised.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94310.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors aimed to uncover what role, if any, the UFD1/NPL4 complex might play in innate immune responses of the nematode C. elegans. The authors find that loss of the complex renders animals more sensitive to both pathogenic and non-pathogenic bacteria. However, there appears to be a complex interplay with known innate immune pathways since loss of UFD1/NPL4 actually results in increased survival of animals lacking the canonical innate immune pathways.</p>
<p>Strengths:</p>
<p>The authors perform robust genetic analysis to exclude and include possible mechanisms by which the UFD1/NPL4 pathway acts in the innate immune response.</p>
<p>Weaknesses:</p>
<p>The argument that the loss of the UFD1/NPL4 complex triggers a response that mimics that of an intracellular pathogen is not thoroughly investigated. Additionally, the finding of a role of the GATA transcription factor, ELT-2, in this response is suggestive, but experiments showing sufficiency in the context of loss of the UFD1/NPL4 complex need to be explored.</p>
<p>Comments on revisions:</p>
<p>The authors have performed several control experiments for their RNAi based experiments and also tested the requirement for xbp-1s in their paradigm. The findings and their interpretations are acceptable.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.94310.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Rajneesh</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aballay</surname>
<given-names>Alejandro</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5975-3352</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Jogender</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7947-0405</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>(1) I suggest that the author's choose a different term in their title, abstract and manuscript to describe the phenotypes associated with ufd-1 and npl-4 knockdown other than an &quot;inflammation-like response.&quot; Inflammation is a pathological term with four cardinal signs: redness (rubor), swelling (tumor), warmth (calor) and pain (dolor). These are not symptoms know to occur in C. elegans. The authors could consider using &quot;tolerance&quot; instead, as this term may better describe their findings.</p>
</disp-quote>
<p>We have changed “inflammation-like response” to “aberrant immune response” throughout the manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(2) It would help the reader to better understand the novelty of the findings in this study if the authors include a paragraph in their introduction to put their results in context of the published literature that has examined the relationship between immune activation and nematode health and survival. In particular, I suggest that the authors discuss doi:10.7554/eLife.74206 (2022), a study that charcterized a similar observation to what the authors are reporting. This study found that low cholesterol reduces pathogen tolerance and host survival during pathogen infection. Cholesterol scarcity increases p38 PMK-1 phosphorylation, priming immune effector induction in a manner that reduces pathogen accumulation in the intestine during a subsequent infection. I also suggest that the authors highlight in this introductory paragraph that the toxic effects of inappropriate immune activation in C. elegans has been widely catalogued. For example: doi.org/10.1371/journal.ppat.1011120 (2023); doi:10.1186/s12915-016-0320-z (2016).; doi:10.1126/science.1203411 (2011); doi:10.1534/g3.115.025650 (2016).</p>
<p>In this context, the authors could consider re-wording their novelty claim in the abstract and introduction to take into account this previous body of work.</p>
</disp-quote>
<p>We have added a paragraph to the Discussion section to place our findings in the context of previous research. The revised manuscript now includes the following text (page 11, lines 336–344): “Previous studies have shown that hyperactivation of immune pathways can negatively affect organismal development. For example, sustained activation of the p38 MAPK pathway impairs development in C. elegans (Cheesman et al., 2016; Kim et al., 2016), and excessive activation of the IPR also leads to developmental defects (Lažetić et al., 2023). Similar to our current study, recent work has demonstrated that heightened immune responses can reduce gut pathogen load while paradoxically decreasing host survival during infection (Ghosh and Singh, 2024; Peterson et al., 2022). However, our study uniquely shows that while such heightened immune responses are detrimental to immunocompetent animals, they can be beneficial in the context of immunodeficiency.”</p>
<disp-quote content-type="editor-comment">
<p>(3) The authors rely on the use of RNAi of ufd-1 and npl-4 to study their effect on P. aeruginosa colonization and pathogen resistance throughout the manuscript. To address the possibility of off-target effects of the RNAi, the authors should consider both (i) showing with qRT-PCR that these genes are indeed targeted during RNAi, and (ii) confirming their phenotypes with an orthologous technique, preferably by studying ufd-1 and npl-4 loss-offunction mutants [both in the wild-type and sek-1(km4) backgrounds]. If mutation of these genes is lethal, the authors could use Auxin Inducible Degron (AID) technology to induce the degradation of these proteins in post-developmental animals.</p>
</disp-quote>
<p>We attempted several protocols of CRISPR in our laboratory to generate ufd-1 loss-of-function mutants; however, these efforts were unsuccessful. While this does not rule out the possibility of generating ufd-1 mutants, the failure is likely due to technical limitations on our part rather than an inherent inability to disrupt the gene. Nevertheless, to confirm the specificity of our RNAi-based approach, we quantified ufd-1 and npl-4 mRNA levels following RNAi treatment and found that each gene was specifically and effectively downregulated by its respective RNAi.</p>
<p>Importantly, ufd-1 and npl-4 RNA sequences do not share significant homology, yet knockdown of either gene results in nearly identical phenotypes, including reduced survival on P. aeruginosa, diminished intestinal colonization, and shortened lifespan. These consistent outcomes strongly support the conclusion that the phenotypes are attributable to the disruption of the functional UFD-1-NPL-4 complex. We have added these results in the revised manuscript (pages 4-5, lines 114-125): “To confirm the specificity of the RNAi knockdowns and rule out potential off-target effects, we examined transcript levels of ufd-1 and npl-4 following RNAi treatment. RNAi against ufd-1 significantly reduced ufd-1 mRNA levels without reducing npl-4 expression, while npl-4 RNAi specifically downregulated npl-4 transcripts with no impact on ufd-1 mRNA levels (Figure 1—figure supplement 1A and B). Additionally, alignment of ufd-1 and npl-4 mRNA sequences against the C. elegans transcriptome revealed no significant similarity to other genes, supporting the specificity of the RNAi constructs. Moreover, the ufd-1 and npl-4 RNA sequences do not share significant sequence similarity. Therefore, the highly similar phenotypes observed in ufd-1 and npl-4 knockdown animals, including shortened lifespan, reduced survival on P. aeruginosa, and decreased intestinal colonization with P. aeruginosa, strongly suggest that these outcomes result from the disruption of the functional UFD-1-NPL-4 complex.”</p>
<disp-quote content-type="editor-comment">
<p>(4) I am confused about the authors explanation regarding their observation that inhibition of the UFD-1/ NPL-4 complex extends the lifespan of sek-1(km25) animals, but not pmk-1(km25) animals, as SEK-1 is the MAPKK that functions immediately upstream of the p38 MAPK PMK-1 to promote pathogen resistance.</p>
<p>I am also confused why their RNA-seq experiment revealed a signature of intracellular pathogen response genes and not PMK-1 targets, which the authors propose is accounting for toxic immune activation. Activation of which immune response leads to toxicity?</p>
</disp-quote>
<p>We consistently observe that sek-1(km4) mutants are more sensitive to P. aeruginosa infection than pmk-1(km25) mutants, a finding also reported in previous studies (for example, PMID: 33658510). Given that SEK-1 functions upstream of PMK-1 in the MAPK signaling cascade, it is plausible that SEK-1 also regulates additional MAP kinases, such as PMK-2 (PMID: 25671546), which could contribute to the enhanced susceptibility observed in sek-1 mutants.</p>
<p>Our results show that inhibition of the UFD-1-NPL-4 complex improves survival specifically in severely immunocompromised animals, such as sek-1(km4) mutants, but not in pmk1(km25) mutants. To further validate this, we generated the double mutant dbl-1(nk3);pmk1(km25), which exhibits reduced survival on P. aeruginosa compared to either single mutant.</p>
<p>Notably, inhibition of the UFD-1-NPL-4 complex also enhances survival in the dbl1(nk3);pmk-1(km25) background, reinforcing the observation that this response is specific to severely compromised immune states.</p>
<p>We would also like to clarify that the observed phenotypes are independent of the SEK1/PMK-1 pathway, as shown in Figure 3A-3C, Figure 3—figure supplement 1, and Figure 4A-4C. The IPR seems to play a role in the observed phenotypes, as inhibition of some of the protease and pals genes (IPR genes) leads to increased P. aeruginosa colonization in ufd-1 knockdown animals (Figure 6—figure supplement 1). The other immune response pathway that leads to the observed phenotypes is ELT-2, as explained in Figure 6. Finally, we have included in the revised manuscript a note that, in addition, as-yet unidentified pathways are also likely contributing to the phenotypes triggered by disruption of the UFD-1-NPL-4 complex.</p>
<disp-quote content-type="editor-comment">
<p>(5) The authors did not test alternative explanations for why UFD-1/ NPL-4 complex inhibition compromises survival during pathogen infection, other than exuberant immune activation. For example, it is possible that inhibition of this proteosome complex shortens lifespan by compromising the general health/ normal physiology of nematodes. Immune responses could be activated as a secondary consequence of this stress, and not be a direct cause of early morality. Does sek-1(km4) mutant suppress the lifespan shortened lifespan of ufd-1 and npl-4 knockdown? This experiment should also be done with loss-offunction mutants, as noted in point 3.</p>
</disp-quote>
<p>We have already included this data in Figure 4D, where we observed that ufd-1 and npl-4 knockdown reduce the lifespan of sek-1(km4) animals. It is possible that immune activation is a secondary consequence of cellular stress induced by inhibition of the UFD-1NPL-4 complex. However, our data strongly suggest that the observed phenotypes, including reduced gut pathogen load and decreased survival on the pathogen, are due to the aberrant immune response activated by the inhibition of the UFD-1-NPL-4 complex. Evidence from sek-1(km4) mutants particularly underscores the role of this dysregulated immune activation. While this aberrant immune response is detrimental to wild-type animals under pathogenic conditions, it appears to be beneficial in severely immunocompromised backgrounds. Specifically, in sek-1(km4) mutants, inhibition of the UFD-1-NPL-4 complex enhances survival during P. aeruginosa infection (Figure 4A). However, under non-infectious conditions, where sek-1(km4) mutants exhibit a normal lifespan, the same immune activation becomes harmful (Figure 4D). Together, these findings demonstrate that the aberrant immune response induced by UFD-1–NPL-4 inhibition is context-dependent: it is advantageous only for immunocompromised animals under infection, but deleterious to healthy animals under infection and to both healthy and immunocompromised animals under non-infectious conditions.</p>
<disp-quote content-type="editor-comment">
<p>(6) The conclusion of Figure 6 hinges on an experiments that uses double RNAi to knockdown two genes at the same time (Fig. 6D and 6G), an approach that is inherently fraught in C. elegans biology owing the likelihood that the efficiency of RNAi-mediated gene knockdown is compromised and may account for the observed phenotypes. The proper control for double RNAi is not empty vector + ufd-1(RNAi), but rather gfp(RNAi) + ufd1(RNAi), as the introduction of a second hairpin RNA is what may compromise knockdown efficiency. In this context, it is important to confirm that knockdown of both genes occurs as expected (with qRT-PCR) and to confirm this phenotype using available elt-2 loss-of-function mutants.</p>
</disp-quote>
<p>We thank the reviewer for this helpful suggestion. We have repeated all double</p>
<p>RNAi experiments using gfp RNAi as a control instead of the empty vector (Figure 6 and Figure 6—figure supplement 1). Additionally, we assessed the efficiency of gene knockdown in the double RNAi conditions (Figure 6—figure supplement 2) and found that RNAi efficacy was not compromised by the double RNAi treatment.</p>
<disp-quote content-type="editor-comment">
<p>(7) A supplementary table with the source data for at least three replications (mean lifespan, n, statistical comparison) for each pathogenesis assay should be included in this manuscript.</p>
</disp-quote>
<p>The source data is provided for all the data presented in the manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>The authors aimed to uncover what role, if any, the UFD1/NPL4 complex might play in the innate immune responses of the nematode C. elegans. The authors find that loss of the complex renders animals more sensitive to both pathogenic and non-pathogenic bacteria. However, there appears to be a complex interplay with known innate immune pathways since the loss of UFD1/NPL4 actually results in increased survival of animals lacking the canonical innate immune pathways.</p>
</disp-quote>
<p>We thank the reviewer for providing an excellent summary of our work.</p>
<disp-quote content-type="editor-comment">
<p>Strengths:</p>
<p>The authors perform robust genetic analysis to exclude and include possible mechanisms by which the UFD1/NPL4 pathway acts in the innate immune response.</p>
</disp-quote>
<p>We thank the reviewer for highlighting the strengths of our work.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>The argument that the loss of the UFD1/NPL4 complex triggers a response that mimics that of an intracellular pathogen has not been thoroughly investigated. Additionally, the finding of a role of the GATA transcription factor, ELT-2, in this response is suggestive, but experiments showing sufficiency in the context of loss of the UFD1/NPL4 complex need to be explored.</p>
</disp-quote>
<p>We have investigated the role of IPR genes in the phenotypes observed upon ufd1 knockdown (Figure 6—figure supplement 1), and our results suggest that the IPR may contribute, at least in part, to the phenotypic outcomes of ufd-1 RNAi. In the Discussion section (pages 11–12, lines 345–356), we have included a detailed discussion on the possible mechanisms underlying IPR activation upon inhibition of the UFD-1–NPL-4 complex. We agree that the interaction between the UFD-1–NPL-4 complex and the IPR is intriguing and warrants further investigation. However, we believe that an in-depth exploration of this interaction lies beyond the scope of the current study.</p>
<p>We have incorporated new data on ELT-2 overexpression in the revised manuscript. Overexpression of ELT-2 partially phenocopies the effects of ufd-1 knockdown, supporting the idea that other pathways likely contribute to the full spectrum of phenotypes observed upon UFD-1-NPL-4 complex inhibition. The revised manuscript reads (page 10, lines 311319): “To determine whether ELT-2 activation alone is sufficient to recapitulate the phenotypes observed upon UFD-1-NPL-4 complex inhibition, we analyzed animals overexpressing ELT-2. Similar to ufd-1 knockdown, ELT-2 overexpression led to a significant reduction in the colonization of the gut by P. aeruginosa (Figure 6—figure supplement 3A and 3B). However, overexpression of ELT-2 did not alter the survival of worms on P. aeruginosa (Figure 6—figure supplement 3C). Taken together, these findings suggest that the phenotypes triggered by disruption of the UFD-1-NPL-4 complex are partially mediated by ELT-2. However, additional pathways, yet to be identified, likely cooperate with ELT-2 to regulate both pathogen resistance and host survival.”</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p>
<p>The authors could consider avoiding the use of descriptors (e.g., &quot;drastic&quot;) when presenting their data.</p>
</disp-quote>
<p>We have removed the descriptors.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p>
<p>What happens with overexpression of ELT2?</p>
</disp-quote>
<p>Overexpression of ELT-2 partially recapitulates the phenotypes of ufd-1 knockdowns, indicating that additional pathways are likely involved in controlling the phenotypes observed upon inhibition of the UFD-1-NPL-4 complex. The revised manuscript reads (page 10, lines 311-319): “To determine whether ELT-2 activation alone is sufficient to recapitulate the phenotypes observed upon UFD-1-NPL-4 complex inhibition, we analyzed animals overexpressing ELT-2. Similar to ufd-1 knockdown, ELT-2 overexpression led to a significant reduction in the colonization of the gut by P. aeruginosa (Figure 6—figure supplement 3A and 3B). However, overexpression of ELT-2 did not alter the survival of worms on P. aeruginosa (Figure 6—figure supplement 3C). Taken together, these findings suggest that the phenotypes triggered by disruption of the UFD-1-NPL-4 complex are partially mediated by ELT-2. However, additional pathways, yet to be identified, likely cooperate with ELT-2 to regulate both pathogen resistance and host survival.”</p>
<disp-quote content-type="editor-comment">
<p>The data with xbp-1 loss of function is very different than that of pek1 and atf-6. Does loss of ufd1/npl4 suppress the increased pathogen survival of xbp-1s overexpressing animals?</p>
</disp-quote>
<p>We have examined worms overexpressing XBP-1s and found that overexpression of XBP-1s does not rescue the phenotypes caused by ufd-1 knockdown. The revised manuscript reads (page 6, lines 167-174): “To further examine the role of XBP-1 in this context, we assessed the effect of ufd-1 knockdown in animals neuronally overexpressing the constitutively active spliced form of XBP-1 (XBP-1s), which has been previously associated with enhanced longevity (Taylor and Dillin, 2013). Knockdown of ufd-1 resulted in the reduced survival of XBP-1s-overexpressing animals on P. aeruginosa, despite a concurrent decrease in bacterial colonization of the gut (Figure 2—figure supplement 1A-C). This indicated that the XBP-1 pathway was not required for the reduced P. aeruginosa colonization of ufd-1 knockdown animals.”</p>
<disp-quote content-type="editor-comment">
<p>Lastly, while the pathogen burden is reduced in ufd1/npl4 loss and pumping rates are marginally affected, have you checked defecation rates? Could they be increased?</p>
</disp-quote>
<p>We thank the reviewer for this valuable suggestion. We measured defecation rates following ufd-1 and npl-4 knockdown and, unexpectedly, found that inhibition of ufd-1/npl-4 leads to a reduction in defecation frequency. These findings clearly indicate that altered defecation cannot explain the observed decrease in gut colonization. The revised manuscript reads (page 5, lines 138-148): “The clearance of intestinal contents through the defecation motor program (DMP) is known to influence gut colonization by P. aeruginosa in C. elegans (Das et al., 2023). It is therefore conceivable that knockdown of the UFD-1-NPL-4 complex might increase defecation frequency, thereby promoting the physical expulsion of bacteria and resulting in reduced gut colonization. To test this possibility, we measured DMP rates in animals subjected to ufd-1 and npl-4 RNAi. Contrary to this hypothesis, both ufd-1 and npl-4 knockdown animals exhibited a significant reduction in defecation frequency compared to control RNAi-treated animals (Figure 1—figure supplement 2C). This reduction in DMP rate persisted even after 12 hours of exposure to P. aeruginosa (Figure 1—figure supplement 2D). Thus, the change in the DMP rate in ufd-1 and npl-4 knockdown animals is unlikely to be the reason for the reduced gut colonization by P. aeruginosa.”</p>
<p>In summary, we would like to thank the reviewers again for providing constructive and thoughtful feedback. We believe we have fully addressed all the concerns of the reviewers by carrying out several new experiments and modifying the text. The manuscript has undergone substantial revision and has thereby improved significantly. We do hope that the evidence in support of the conclusions is found to be complete in the revised manuscript.</p>
</body>
</sub-article>
</article>